"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. . "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. amprenavir. this classification denotes a protease inhibitor with the molecular formula c25h35n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5s0w860xnr, chemically known as 4-amino-n-((2 syn,3s)-2-hydroxy-4-phenyl-3-((s)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-n-isobutyl-benzenesulfonamide but generally known as amprenavir, which bears us nih compound identifier 65016. amprenavir most often comes in base, phosphate, and phosphate calcium forms. european medicines agency schedules amprenavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00511mig. the term amprenavir is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 1, 1999, list 41). world health organization schedules amprenavir in its anatomical therapeutic chemical (atc) classification. most nations schedule amprenavir under hs 29350090 and sitc 51580. as of q4 2014, amprenavir remains the us fda preferred term for this commodity. amprenavir bears us nlm identifiers umls id c0754188 and nci concept code c28824. smiles: s(=o)(=o)(n(cc(o)c(nc(=o)oc1ccoc1)cc1ccccc1)cc(c)c)c1ccc(n)cc1.. "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. fosamprenavir. this classification denotes a protease inhibitor with the molecular formula c25h36n3o9ps, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wou1621eeg, chemically known as carbamic acid, ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, c-((3s)-tetrahydro-3-furanyl) ester but generally known as fosamprenavir, which bears us nih compound identifier 131536. european medicines agency schedules fosamprenavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25386. the term fosamprenavir is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). world health organization schedules fosamprenavir in its anatomical therapeutic chemical (atc) classification. most nations schedule fosamprenavir under hs 29350090 and sitc 51580. as of q4 2014, fosamprenavir remains the us fda preferred term for this commodity. fosamprenavir bears us nlm identifiers umls id c1176315 and nci concept code c83720. smiles: s(=o)(=o)(n(cc(op(=o)(o)o)c(nc(=o)oc1ccoc1)cc1ccccc1)cc(c)c)c1ccc(n)cc1.. "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. foscarnet. this classification denotes a reverse transcriptase inhibitor with the molecular formula ch3o5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 364p9rvw4x, chemically known as phosphinecarboxylic acid, dihydroxy-, oxide but generally known as foscarnet, which bears us nih compound identifier 3415. european medicines agency schedules foscarnet in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02258mig. world health organization schedules foscarnet in its anatomical therapeutic chemical (atc) classification. as of q4 2014, foscarnet remains the us fda preferred term for this commodity. foscarnet bears us nlm identifiers umls id c0070895 and nci concept code c71630. smiles: p(=o)(o)(o)c(=o)o.. "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. fosfonet. this classification denotes a reverse transcriptase inhibitor and antiviral agent with the molecular formula c2h5o5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n919e46723, chemically known as phosphonoacetic acid, disodium salt, monohydrate but generally known as fosfonet, which bears us nih compound identifier 546. world health organization schedules fosfonet in its anatomical therapeutic chemical (atc) classification. fosfonet is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c(c(=o)o)p(=o)(o)o.. "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. fosamprenavir calcium. this classification denotes a protease inhibitor c25h34n3o9ps.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier id1gu2627n, chemically known as (3s)-tetrahydro-3-furyl ((.alpha.s)-.alpha.-((1r)-1-hydroxy-2-(n1-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1), but more generally known as fosamprenavir calcium, which bears us nih compound identifier 131535. european medicines agency schedules fosamprenavir calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20055. most nations, for tariff and trade purposes, schedule fosamprenavir calcium under hs 29350090 and sitc 51580. as of q4 2014, fosamprenavir calcium remains us fdas preferred term for this commodity. fosamprenavir calcium bears us nlm identifiers umls id c1320129 and nci concept code c61771. smiles: cc(c)cn(c[c@h]([c@h](cc1ccccc1)nc(=o)o[c@h]2ccoc2)op(=o)([o-])[o-])s(=o)(=o)c3ccc(cc3)n.[ca+2].. "
"antiviral carboxylic acids. antiviral drugs made from organic compounds containing the carboxy group (-cooh).. fosamprenavir sodium. this classification denotes an enzyme inhibitor with the molecular formula c25h34n3o9ps.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xsg28fsa0w, chemically known as carbamic acid, ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, c-((3s)-tetrahydro-3-furanyl) ester, disodium salt but more generally known as fosamprenavir sodium, which bears us nih compound identifier 131537. most nations, for tariff and trade purposes, schedule fosamprenavir sodium under hs 29350090 and sitc 51580. as of q4 2014, fosamprenavir sodium remains us fdas preferred term for this commodity. fosamprenavir sodium bears us nlm identifiers umls id c1366241 and nci concept code c72786. smiles: cc(c)cn(c[c@h]([c@h](cc1ccccc1)nc(=o)o[c@h]2ccoc2)op(=o)([o-])[o-])s(=o)(=o)c3ccc(cc3)n.[na+].[na+].. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. . "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. somantadine. this classification denotes an antiviral agent with the molecular formula c14h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 02wmx1fs9y chemically known as .alpha.,.alpha.-dimethyl-1-adamantaneethylamine but generally known as somantadine, which bears us nih compound identifier 600809. european medicines agency schedules somantadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10580mig. the term somantadine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24. ). most nations schedule somantadine under hs 29213099 and sitc 51453. as of q4 2014, somantadine remains the us fda preferred term for this commodity. somantadine bears us nlm identifiers umls id c2827334 and nci concept code c84174. smiles: ncc(c12cc3cc(c2)cc(c1)c3)(c)c.. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. tromantadine. this classification denotes an antiviral agent with the molecular formula c16h28n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h191jfg8wa, chemically known as 2-(2-(dimethylamino)ethoxy)-n-tricyclo(3.3.1.13,7)dec-1-ylacetamide but generally known as tromantadine, which bears us nih compound identifier 64377. european medicines agency schedules tromantadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11335mig. the term tromantadine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules tromantadine in its anatomical therapeutic chemical (atc) classification. tromantadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tromantadine under hs 29242995 and sitc 51479. as of q4 2014, tromantadine remains the us fda preferred term for this commodity. tromantadine bears us nlm identifiers umls id c0077379 and nci concept code c81608. smiles: o=c(nc12cc3cc(c2)cc(c1)c3)coccn(c)c.. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. rimantadine. this classification denotes an antiviral agent with the molecular formula c12h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0t2ef4jqtu, chemically known as 1-adamantanemethylamine, .alpha.-methyl-, hydrochloride but generally known as rimantadine, which bears us nih compound identifier 5071. european medicines agency schedules rimantadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10320mig. the term rimantadine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules rimantadine in its anatomical therapeutic chemical (atc) classification. rimantadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rimantadine under hs 29213099 and sitc 51453. as of q4 2014, rimantadine remains the us fda preferred term for this commodity. rimantadine bears us nlm identifiers umls id c0035629 and nci concept code c61927. smiles: nc(c12cc3cc(c2)cc(c1)c3)c.. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. rimantadine hydrochloride. this classification denotes a pegylated interferon alfa with the molecular formula c10h18n3o5(c2h4o)n(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q46947fe7k. european medicines agency schedules peginterferon alfa-2a in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16452mig. the term peginterferon alfa-2a is a european medicines agency european public assessment report system designation. most nations schedule rimantadine hydrochloride under hs 29213099 and sitc 51453. as of q4 2014, rimantadine hydrochloride remains the us fda preferred term for this commodity. rimantadine hydrochloride bears us nlm identifiers umls id c0733408 and nci concept code c61928. smiles: none.. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. somantadine hydrochloride. this classification denotes an antiviral agent with the molecular formula c14h25n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i505ki9f8q, chemically known as 2-(1-adamantyl)-1,1-dimethylethylamin hydrochlorid but more generally known as somantadine hydrochloride, which bears us nih compound identifier 3033453. most nations, for tariff and trade purposes, schedule somantadine hydrochloride under hs 29213099 and sitc 51453. as of q4 2014, somantadine hydrochloride remains us fdas preferred term for this commodity. somantadine hydrochloride bears us nlm identifiers umls id c2825701 and nci concept code c81610. smiles: cc(c)(c[c@]12c[c@@h]3c[c@h](c1)cc(c3)c2)n.cl.. "
"antiviral adamantanes. antiviral drugs made from a bridged compound and a cycloalkane (c10h16).. tromantadine hydrochloride. this classification denotes an antiviral agent with the molecular formula c16h28n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h09lus437b, chemically known as acetamide, n-1-adamantyl-n-(2-(dimethylamino)ethoxy)-, hydrochloride but more generally known as tromantadine hydrochloride, which bears us nih compound identifier 64284. european medicines agency schedules tromantadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04992mig. most nations, for tariff and trade purposes, schedule tromantadine hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, tromantadine hydrochloride remains us fdas preferred term for this commodity. tromantadine hydrochloride bears us nlm identifiers umls id c1529464 and nci concept code c96719. smiles: cn(c)ccocc(=o)n[c@]12c[c@@h]3c[c@h](c1)cc(c3)c2.cl.. "
"antiviral aldehydes. antiviral drugs made from organic compounds containing a carbonyl group in the form -cho.. . "
"antiviral aldehydes. antiviral drugs made from organic compounds containing a carbonyl group in the form -cho.. kethoxal or ketoxal. this classification denotes an antiviral agent with the molecular formula c6h12o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e00mdp82s4, chemically known as 3-ethoxy-1,1-dihydroxy-2-butanone but generally known as kethoxal, which bears us nih compound identifier 34006. european medicines agency schedules ketoxal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08379mig. the term ketoxal is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). kethoxal or ketoxal bears us nlm identifiers umls id c0064305 and nci concept code c83855. smiles: ccoc(c)c(=o)c(o)o.. "
"antiviral aldehydes. antiviral drugs made from organic compounds containing a carbonyl group in the form -cho.. xenygloxal. this classification denotes an antiviral agent and antimicrobial with the molecular formula c16h10o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3c2t3hg40e, chemically known as 4,4-diphenyldicarboxaldehyde but generally known as xenygloxal, which bears us nih compound identifier 239061. european medicines agency schedules xenygloxal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00106mig. the term xenygloxal is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). xenygloxal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule xenygloxal under hs 29144090 and sitc 51629. as of q4 2014, xenygloxal remains the us fda preferred term for this commodity. xenygloxal bears us nlm identifiers umls id c1883575 and nci concept code c66666. smiles: o=c(c1ccc(c2ccc(cc2)c(=o)c=o)cc1)c=o.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. . "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. darunavir. this classification denotes a protease inhibitor with the molecular formula c27h37n3o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yo603y8113, chemically known as n-((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1s,2r,5r)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide but generally known as darunavir, which bears us nih compound identifier 213039. european medicines agency schedules darunavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25394. the term darunavir is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules darunavir in its anatomical therapeutic chemical (atc) classification. most nations schedule darunavir under hs 29350090 and sitc 51580. as of q4 2014, darunavir remains the us fda preferred term for this commodity. darunavir bears us nlm identifiers umls id c1435444 and nci concept code c65364. smiles: s(=o)(=o)(n(cc(o)c(nc(=o)oc1c2c(oc1)occ2)cc1ccccc1)cc(c)c)c1ccc(n)cc1.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. oseltamivir. this classification denotes an antiviral agent with the molecular formula c16h28n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 20o93l6f9h, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but generally known as oseltamivir, which bears us nih compound identifier 65028. european medicines agency schedules oseltamivir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03553mig. the term oseltamivir is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules oseltamivir in its anatomical therapeutic chemical (atc) classification. most nations schedule oseltamivir under hs 29242995 and sitc 51479. as of q4 2014, oseltamivir remains the us fda preferred term for this commodity. oseltamivir bears us nlm identifiers umls id c0874161 and nci concept code c62061. smiles: o(c1c(nc(=o)c)c(n)cc(=c1)c(=o)occ)c(cc)cc.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. darunavir ethanolate. this classification denotes a protease inhibitor c27h37n3o7s.c2h6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33o78xf0bw, chemically known as ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)- carbamic acid (3r,3as,6ar)-hexahydrofuro(2,3-b)furan-3-yl ester monoethanolate, but more generally known as darunavir ethanolate, which bears us nih compound identifier 23725083. european medicines agency schedules darunavir ethanolate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23573. most nations, for tariff and trade purposes, schedule darunavir ethanolate under hs 29350090 and sitc 51580. as of q4 2014, darunavir ethanolate remains us fdas preferred term for this commodity. darunavir ethanolate bears us nlm identifiers umls id c1725651 and nci concept code c77389. smiles: cco.cc(c)cn(c[c@h]([c@h](cc1ccccc1)nc(=o)o[c@h]2co[c@@h]3[c@h]2cco3)o)s(=o)(=o)c4ccc(cc4)n.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. oseltamivir carboxylate. this classification denotes an antiviral agent with the molecular formula c14h24n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k6106lv5q8, chemically known as oseltamivir acid, (-)-, but more generally known as oseltamivir carboxylate, which bears us nih compound identifier 449381. european medicines agency schedules oseltamivir carboxylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03553mig. most nations, for tariff purposes, schedule oseltamivir carboxylate under hs 29242995. smiles: ccc(cc)o[c@@h]1c=c(c[c@@h]([c@h]1nc(=o)c)n)c(=o)o.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. oseltamivir phosphate. this classification denotes an antiviral agent with the molecular formula c16h28n2o4.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4a3o49ngez, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but more generally known as oseltamivir phosphate, which bears us nih compound identifier 65028. european medicines agency schedules oseltamivir phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12544mig. most nations, for tariff and trade purposes, schedule oseltamivir phosphate under hs 29242995 and sitc 51479. as of q4 2014, oseltamivir phosphate remains us fdas preferred term for this commodity. oseltamivir phosphate bears us nlm identifiers umls id c0872908 and nci concept code c29305. smiles: ccc(cc)o[c@@h]1c=c(c[c@@h]([c@h]1nc(=o)c)n)c(=o)occ.op(=o)(o)o.. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. sofosbuvir. antiviral for the treatment of hepatitis c virus infections. "
"antiviral amides. antiviral drugs made from organic compounds containing the -co-nh2 radical, derived from acids by replacement of -oh by -nh2 or from ammonia by the replacement of h by an acyl group.. daclatasvir. antiviral for the treatment of hepatitis c virus infections. "
"antiviral amidines and amines and benzoxazines and cyclohexanes. this classification denotes antiviral drugs made from or based in part on amidines, amines, benzoxazines, or cyclohexanes. . "
"antiviral amidines and amines and benzoxazines and cyclohexanes. this classification denotes antiviral drugs made from or based in part on amidines, amines, benzoxazines, or cyclohexanes. zanamivir. this classification denotes an antiviral agent with the molecular formula c12h20n4o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l6o3xi777i, chemically known as 5-acetamido-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic acid but generally known as zanamivir, which bears us nih compound identifier 60855. european medicines agency schedules zanamivir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00137mig. the term zanamivir is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). world health organization schedules zanamivir in its anatomical therapeutic chemical (atc) classification. zanamivir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zanamivir under hs 29329985 and sitc 51569. as of q4 2014, zanamivir remains the us fda preferred term for this commodity. zanamivir bears us nlm identifiers umls id c0216660 and nci concept code c47786. smiles: o1c(c(nc(=o)c)c(/n=c(/n)n)c=c1c(=o)o)c(o)c(o)co.. "
"antiviral amidines and amines and benzoxazines and cyclohexanes. this classification denotes antiviral drugs made from or based in part on amidines, amines, benzoxazines, or cyclohexanes. zinviroxime. this classification denotes an antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9swb3p2o2s. european medicines agency schedules zinviroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00166mig. zinviroxime generally arises in the molecular formula c17h18n4o3s. the term zinviroxime is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) zinviroxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zinviroxime under hs 29350090 and sitc 51580. as of q4 2014, zinviroxime remains the us fda preferred term for this commodity. zinviroxime bears us nlm identifiers umls id c2987040 and nci concept code c95289. smiles: s(=o)(=o)(n1c2c(nc1n)ccc(c2)/c(=n\\o)c1ccccc1)c(c)c.. "
"antiviral amidines and amines and benzoxazines and cyclohexanes. this classification denotes antiviral drugs made from or based in part on amidines, amines, benzoxazines, or cyclohexanes. efavirenz. this classification denotes a reverse transcriptase inhibitor with the molecular formula c14h9clf3no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier je6h2o27p8, chemically known as 2h-3,1-benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4s)- but generally known as efavirenz, which bears us nih compound identifier 64139. european medicines agency schedules efavirenz in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06463mig. the term efavirenz is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules efavirenz in its anatomical therapeutic chemical (atc) classification. most nations schedule efavirenz under hs 29349990 and sitc 51579. as of q4 2014, efavirenz remains the us fda preferred term for this commodity. efavirenz bears us nlm identifiers umls id c0674428 and nci concept code c29027. smiles: clc1cc2c(oc(=o)nc2cc1)(c#cc1cc1)c(f)(f)f.. "
"antiviral amidines and amines and benzoxazines and cyclohexanes. this classification denotes antiviral drugs made from or based in part on amidines, amines, benzoxazines, or cyclohexanes. maraviroc. this classification denotes a chemokine receptor antagonist and anti-hiv agent with the molecular formula c29h41f2n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier md6p741w8a, chemically known as uk-427,857 but generally known as maraviroc, which bears us nih compound identifier 3002977. european medicines agency schedules maraviroc in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25224. the term maraviroc is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53). world health organization schedules maraviroc in its anatomical therapeutic chemical (atc) classification. most nations schedule maraviroc under hs 29333999 and sitc 51574. as of q4 2014, maraviroc remains the us fda preferred term for this commodity. maraviroc bears us nlm identifiers umls id c1667052 and nci concept code c73144. smiles: fc1(f)ccc(c(=o)nc(ccn2c3cc(n4c(nnc4c)c(c)c)cc2cc3)c2ccccc2)cc1.. "
"antiviral azoles. antiviral drugs made from five membered rings containing a nitrogen atom.. . "
"antiviral azoles. antiviral drugs made from five membered rings containing a nitrogen atom.. capravirine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c20h20cl2n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vhc779598x, chemically known as 5-(3,5-dichlorophenyl)thio-4-isopropyl-1-(pyridin-4-yl-methyl)-1h-imidazol-2-yl-methyl carbamate but generally known as capravirine, which bears us nih compound identifier 1783. european medicines agency schedules capravirine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20328. the term capravirine is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). most nations schedule capravirine under hs 29333999 and sitc 51574. as of q4 2014, capravirine remains the us fda preferred term for this commodity. capravirine bears us nlm identifiers umls id c0755617 and nci concept code c81612. smiles: clc1cc(sc2n(c(nc2c(c)c)coc(=o)n)cc2ccncc2)cc(cl)c1.. "
"antiviral azoles. antiviral drugs made from five membered rings containing a nitrogen atom.. disoxaril. this classification denotes an antiviral agent with the molecular formula c20h26n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fx8q9pi4vp, chemically known as 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole but generally known as disoxaril, which bears us nih compound identifier 55717. european medicines agency schedules disoxaril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06322mig. the term disoxaril is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). disoxaril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule disoxaril under hs 29349990 and sitc 51579. as of q4 2014, disoxaril remains the us fda preferred term for this commodity. disoxaril bears us nlm identifiers umls id c0058467 and nci concept code c81607. smiles: o(cccccccc1onc(c1)c)c1ccc(c2=ncco2)cc1.. "
"antiviral azoles. antiviral drugs made from five membered rings containing a nitrogen atom.. pleconaril. this classification denotes an anti-infective agent with the molecular formula c18h18f3n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9h4570q89d, chemically known as 1,2,4-oxadiazole, 3-(3,5-dimethyl-4-(3-(3-methyl-5-isoxazolyl)propoxy)phenyl)-5-(trifluoromethyl)- but generally known as pleconaril, which bears us nih compound identifier 1684. european medicines agency schedules pleconaril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09957mig. the term pleconaril is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). world health organization schedules pleconaril in its anatomical therapeutic chemical (atc) classification. pleconaril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pleconaril under hs 29349990 and sitc 51579. as of q4 2014, pleconaril remains the us fda preferred term for this commodity. pleconaril bears us nlm identifiers umls id c0759032 and nci concept code c81604. smiles: fc(f)(f)c1onc(n1)c1cc(c(occcc2onc(c2)c)c(c1)c)c.. "
"antiviral benzimidazoles. antiviral drugs made from compounds with a benzene fused to imidazoles.. . "
"antiviral benzimidazoles. antiviral drugs made from compounds with a benzene fused to imidazoles.. enviradene. this classification denotes an antiviral agent with the molecular formula c19h21n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9q79a81839, chemically known as 1h-benzimidazol-2-amine, 1-((1-methylethyl)sulfonyl)-6-(1-phenyl-1-propenyl)-, (e)- but generally known as enviradene, which bears us nih compound identifier 6435398. european medicines agency schedules enviradene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06555mig. the term enviradene is an international non-proprietary name. enviradene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enviradene under hs 29339990 and sitc 51577. as of q4 2014, enviradene remains the us fda preferred term for this commodity. enviradene bears us nlm identifiers umls id c0116243 and nci concept code c65514. smiles: s(=o)(=o)(n1c2c(nc1n)ccc(c2)/c(=c/c)c1ccccc1)c(c)c.. "
"antiviral benzimidazoles. antiviral drugs made from compounds with a benzene fused to imidazoles.. enviroxime. this classification denotes an antiviral agent with the molecular formula c17h18n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 133013l556, chemically known as 1h-benzimidazol-2-amine, 6-((hydroxyimino)phenylmethyl)-1-((1-methylethyl)sulfonyl)-, (e)- but generally known as enviroxime, which bears us nih compound identifier 5748733. european medicines agency schedules enviroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06556mig. the term enviroxime is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). enviroxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enviroxime under hs 29350090 and sitc 51580. as of q4 2014, enviroxime remains the us fda preferred term for this commodity. enviroxime bears us nlm identifiers umls id c0059396 and nci concept code c83691. smiles: s(=o)(=o)(n1c2c(nc1n)ccc(c2)/c(=n/o)c1ccccc1)c(c)c.. "
"antiviral benzimidazoles. antiviral drugs made from compounds with a benzene fused to imidazoles.. maribavir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c15h19cl2n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ptb4x93he1, chemically known as 5,6-dichloro-n-(1-methylethyl)-1-beta-l-ribofuranosyl-1h-benzimidazol-2-amine but generally known as maribavir, which bears us nih compound identifier 122872. european medicines agency schedules maribavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03090mig. the term maribavir is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules maribavir in its anatomical therapeutic chemical (atc) classification. most nations schedule maribavir under hs 29349990 and sitc 51579. as of q4 2014, maribavir remains the us fda preferred term for this commodity. maribavir bears us nlm identifiers umls id c1508759 and nci concept code c82254. smiles: clc1cc2n(c3oc(c(o)c3o)co)c(nc(c)c)nc2cc1cl.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. . "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. valaciclovir or valacyclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c13h20n6o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier mz1iw7q79d, chemically known as valaciclovir, valtrex but more generally known as valaciclovir, which bears u.s. national institutes of health compound identifier 60773. the european medicines agency schedules valaciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00003mig. the term valaciclovir is an international non-proprietary name or inn (see world health organization inn reference publication, volume 8 no. 3 1994, list 34). the world health organization schedules valaciclovir in its anatomical therapeutic chemical (atc) classification. valaciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(c)c(c(=o)occocn1c=nc2=c1nc(=nc2=o)n)n.cl.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. buciclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c9h13n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4g4z4676is, chemically known as 6h-purin-6-one, 2-amino-9-(3,4-dihydroxybutyl)-1,9-dihydro-, (r)- but generally known as buciclovir, which bears us nih compound identifier 65648. buciclovir most often comes in base and triphosphate forms. european medicines agency schedules buciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05943mig. the term buciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). buciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule buciclovir under hs 29335995 and sitc 51576. as of q4 2014, buciclovir remains the us fda preferred term for this commodity. buciclovir bears us nlm identifiers umls id c0050178 and nci concept code c73198. smiles: oc(ccn1c2[nh]c(nc(=o)c2nc1)n)co.-.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. desciclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c8h11n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bhm1xxa2ez, chemically known as ethanol, 2-((2-amino-9h-purin-9-yl)methoxy)- but generally known as desciclovir, which bears us nih compound identifier 55256. european medicines agency schedules desciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06990mig. the term desciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). desciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule desciclovir under hs 29335995 and sitc 51576. as of q4 2014, desciclovir remains the us fda preferred term for this commodity. desciclovir bears us nlm identifiers umls id c0113168 and nci concept code c73203. smiles: o(cn1c2nc(ncc2nc1)n)cco.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. entecavir. this classification denotes an antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5968y6h45m. european medicines agency schedules entecavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21468. entecavir generally arises in the molecular formula c12h15n5o3.h2o. the term entecavir is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44.) most nations schedule entecavir under hs 29335995 and sitc 51576. as of q4 2014, entecavir remains the us fda preferred term for this commodity. entecavir bears us nlm identifiers umls id c0971023 and nci concept code c65513. smiles: c=c1c(cc(c1co)o)n2c=nc3=c2nc(=nc3=o)n.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. ganciclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c9h13n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p9g3ckz4p5, chemically known as 9-(1,3-dihydroxy-propoxymethane)guanine but generally known as ganciclovir, which bears us nih compound identifier 3454. european medicines agency schedules ganciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07881mig. the term ganciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules ganciclovir in its anatomical therapeutic chemical (atc) classification. ganciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ganciclovir under hs 29335995 and sitc 51576. as of q4 2014, ganciclovir remains the us fda preferred term for this commodity. ganciclovir bears us nlm identifiers umls id c0017066 and nci concept code c517. smiles: o(c(co)co)cn1c2[nh]c(nc(=o)c2nc1)n.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. lobucavir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c11h15n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8u5pyq1r2e, chemically known as 9-(2,3-bis-(hydroxymethyl)-1-cyclobutyl)guanine but generally known as lobucavir, which bears us nih compound identifier 60786. european medicines agency schedules lobucavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08544mig. the term lobucavir is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). lobucavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lobucavir under hs 29335995 and sitc 51576. as of q4 2014, lobucavir remains the us fda preferred term for this commodity. lobucavir bears us nlm identifiers umls id c0651257 and nci concept code c82253. smiles: c1c(c(c1n2c=nc3=c2nc(=nc3=o)n)co)co.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. penciclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c10h15n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 359hue8fjc, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & human interferon-.gamma. but generally known as penciclovir, which bears us nih compound identifier 4725. european medicines agency schedules penciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09661mig. the term penciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules penciclovir in its anatomical therapeutic chemical (atc) classification. penciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule penciclovir under hs 29335995 and sitc 51576. as of q4 2014, penciclovir remains the us fda preferred term for this commodity. penciclovir bears us nlm identifiers umls id c0164815 and nci concept code c66337. smiles: c1=nc2=c(n1ccc(co)co)nc(=nc2=o)n.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. valganciclovir. this classification denotes a purine antagonist and antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gcu97fkn3r. european medicines agency schedules valganciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00007mig. valganciclovir generally arises in the molecular formula c14h22n6o5. the term valganciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40.) valganciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule valganciclovir under hs 29335995 and sitc 51576. as of q4 2014, valganciclovir remains the us fda preferred term for this commodity. valganciclovir bears us nlm identifiers umls id c0909381 and nci concept code c2629. smiles: cc(c)c(c(=o)occ(co)ocn1c=nc2=c1nc(=nc2=o)n)n.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. aciclovir or acyclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c8h11n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x4hes1o11f, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)- but generally known as aciclovir, which bears us nih compound identifier 2022. aciclovir, also known as acyclovir, most often comes in forms natrium and sodium. european medicines agency schedules aciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05235mig. the term aciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules aciclovir in its anatomical therapeutic chemical (atc) classification. aciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. aciclovir or acyclovir bears us nlm identifiers umls id c0001367 and nci concept code c205. smiles: o(cn1c2[nh]c(nc(=o)c2nc1)n)cco.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. valacyclovir hydrochloride. this classification denotes a purine antagonist and antiviral agent with the molecular formula c13h20n6o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g447s0t1vc, chemically known as l-valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride but generally known as valaciclovir hydrochloride, which bears us nih compound identifier 60772. european medicines agency schedules valaciclovir hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15679mig. as of q4 2014, valacyclovir hydrochloride remains the us fda preferred term for this commodity. valacyclovir hydrochloride bears us nlm identifiers umls id c0771309 and nci concept code c29535. smiles: cl.o(c(=o)c(n)c(c)c)ccocn1c2[nh]c(nc(=o)c2nc1)n.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. aciclovir sodium. this classification denotes a purine antagonist and antiviral agent with the molecular formula c8h10n5o3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 927l42j563, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, monosodium salt but more generally known as aciclovir sodium, which bears us nih compound identifier 50600. the base compound, aciclovir, also known as acyclovir, also comes in base and natrium forms. european medicines agency schedules aciclovir sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00284mig. most nations, for tariff and trade purposes, schedule aciclovir sodium under hs 29335995. smiles: c1nc2c(=o)[n-]c(nc2n1cocco)n.[na+].. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. entecavir hydrate. this classification denotes an antiviral agent with the molecular formula c12h15n5o3.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5968y6h45m, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-((1s,3r,4s)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)- monohydrate, but more generally known as entecavir hydrate, which bears us nih compound identifier 170342. european medicines agency schedules entecavir hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21468. most nations, for tariff purposes, schedule entecavir hydrate under hs 29335995. smiles: c=c1[c@h](c[c@@h]([c@h]1co)o)n2cnc3c2nc([nh]c3=o)n.o.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. ganciclovir sodium. this classification denotes a purine antagonist and antiviral agent with the molecular formula c9h12n5o4.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 02l083w284, chemically known as 9-(1,3-dihydroxy-propoxymethane)guanine but more generally known as ganciclovir sodium, which bears us nih compound identifier 3454. european medicines agency schedules ganciclovir sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02312mig. most nations, for tariff and trade purposes, schedule ganciclovir sodium under hs 29335995 and sitc 51576. as of q4 2014, ganciclovir sodium remains us fdas preferred term for this commodity. ganciclovir sodium bears us nlm identifiers umls id c0282399 and nci concept code c1588. smiles: c1nc2c(=o)[n-]c(nc2n1coc(co)co)n.[na+].. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. penciclovir sodium. this classification denotes a purine antagonist and antiviral agent with the molecular formula c10h14n5o3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p06226385l, chemically known as 1,9-dihydro-2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-6h-purin-6-one monosodium salt but more generally known as penciclovir sodium, which bears us nih compound identifier 656702. most nations, for tariff and trade purposes, schedule penciclovir sodium under hs 29335995 and sitc 51576. as of q4 2014, penciclovir sodium remains us fdas preferred term for this commodity. penciclovir sodium bears us nlm identifiers umls id c0719742 and nci concept code c47656. smiles: c1nc2c(=o)[n-]c(nc2n1ccc(co)co)n.[na+].. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. valaciclovir hydrochloride. this classification denotes a purine antagonist and antiviral agent with the molecular formula c13h20n6o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g447s0t1vc, chemically known as l-valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride but more generally known as valaciclovir hydrochloride, which bears us nih compound identifier 60772. european medicines agency schedules valaciclovir hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15679mig. most nations, for tariff and trade purposes, schedule valaciclovir hydrochloride under hs 29335995. smiles: cc(c)[c@@h](c(=o)occocn1cnc2c1nc([nh]c2=o)n)n.cl.. "
"antiviral guanines. antiviral drugs made from purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.. valganciclovir hydrochloride. this classification denotes the hydrochloride form of a purine antagonist and antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gcu97fkn3r. european medicines agency schedules valganciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00007mig. valganciclovir generally arises in the molecular formula c14h22n6o5. the term valganciclovir is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 2 1999, list 40.) valganciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule valganciclovir hydrochloride under hs 29335995 and sitc 51576. valganciclovir hydrochloride bears us nlm identifiers umls id c0969586 and nci concept code c66648. smiles: as of q4 2014, valganciclovir hydrochloride remains us fdas preferred term for this commodity.. "
"antiviral isoquinolines. antiviral drugs made from a group of compounds with the heterocyclic ring structure of benzo(c)pyridine. the ring structure is characteristic of the group of opium alkaloids such as papaverine.. . "
"antiviral isoquinolines. antiviral drugs made from a group of compounds with the heterocyclic ring structure of benzo(c)pyridine. the ring structure is characteristic of the group of opium alkaloids such as papaverine.. nelfinavir. this classification denotes a protease inhibitor with the molecular formula c32h45n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ho3ogh5d7i, chemically known as 3-isoquinolinecarboxamide, n-(1,1-dimethylethyl)decahydro-2-((2r,3r)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3s,4as,8as)- but generally known as nelfinavir, which bears us nih compound identifier 64143. european medicines agency schedules nelfinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09186mig. the term nelfinavir is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38). world health organization schedules nelfinavir in its anatomical therapeutic chemical (atc) classification. nelfinavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nelfinavir under hs 29334990 and sitc 51575. as of q4 2014, nelfinavir remains the us fda preferred term for this commodity. nelfinavir bears us nlm identifiers umls id c0525005 and nci concept code c29285. smiles: s(cc(nc(=o)c1c(c(o)ccc1)c)c(o)cn1cc2c(cc1c(=o)nc(c)(c)c)cccc2)c1ccccc1.. "
"antiviral isoquinolines. antiviral drugs made from a group of compounds with the heterocyclic ring structure of benzo(c)pyridine. the ring structure is characteristic of the group of opium alkaloids such as papaverine.. saquinavir. this classification denotes a protease inhibitor with the molecular formula c38h50n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l3je09kz2f, chemically known as butanediamide, n1-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3alpha,4aalpha,8aalpha))- but generally known as saquinavir, which bears us nih compound identifier 60787. european medicines agency schedules saquinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10446mig. the term saquinavir is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules saquinavir in its anatomical therapeutic chemical (atc) classification. saquinavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule saquinavir under hs 29334910 and sitc 51575. as of q4 2014, saquinavir remains the us fda preferred term for this commodity. saquinavir bears us nlm identifiers umls id c0286738 and nci concept code c29444. smiles: o=c(nc(c)(c)c)c1n(cc2c(c1)cccc2)cc(o)c(nc(=o)c(nc(=o)c1nc2c(cc1)cccc2)cc(=o)n)cc1ccccc1.. "
"antiviral isoquinolines. antiviral drugs made from a group of compounds with the heterocyclic ring structure of benzo(c)pyridine. the ring structure is characteristic of the group of opium alkaloids such as papaverine.. nelfinavir mesilate or mesylate. this classification denotes a protease inhibitor with the molecular formula c32h45n3o4s.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 98d603vp8v, chemically known as (3s,4as,8as)-n-tert-butyl-2-((2r,3r)-3-(3,2-cresotamido)-2-hydroxy-4-(phenylthio)butyl)decahydro-3-isoquinolinecarboxamide monomethanesulfonate (salt), but more generally known as nelfinavir mesylate, which bears us nih compound identifier 64142. european medicines agency schedules nelfinavir mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09186mig. most nations, for tariff purposes, schedule nelfinavir mesylate under hs 29334990. as of q4 2014, nelfinavir mesylate remains us fdas preferred term for this commodity. nelfinavir mesylate bears us nlm identifiers umls id c0886530 and nci concept code c1624. smiles: cc1c(cccc1o)c(=o)n[c@@h](csc2ccccc2)[c@@h](cn3c[c@h]4cccc[c@h]4c[c@h]3c(=o)nc(c)(c)c)o.cs(=o)(=o)o.. "
"antiviral isoquinolines. antiviral drugs made from a group of compounds with the heterocyclic ring structure of benzo(c)pyridine. the ring structure is characteristic of the group of opium alkaloids such as papaverine.. saquinavir mesilate or mesylate. this classification denotes a protease inhibitor with the molecular formula c38h50n6o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uhb9z3841a, chemically known as butanediamide, n(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1h)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3s-(2(1r*(r*),2s*),3.alpha.,4a.beta.,8a.beta.))-, monomethanesulfonate, but more generally known as saquinavir mesylate, which bears us nih compound identifier 60787. european medicines agency schedules saquinavir mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10446mig. most nations, for tariff purposes, schedule saquinavir mesylate under hs 29334910. as of q4 2014, saquinavir mesylate remains us fdas preferred term for this commodity. saquinavir mesylate bears us nlm identifiers umls id c0286737 and nci concept code c1602. smiles: cc(c)(c)nc(=o)[c@@h]1c[c@@h]2cccc[c@@h]2cn1c[c@h]([c@h](cc3ccccc3)nc(=o)[c@h](cc(=o)n)nc(=o)c4ccc5ccccc5n4)o.cs(=o)(=o)o.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. . "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. abacavir. this classification denotes a reverse transcriptase inhibitor with the molecular formula c14h18n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wr2tip26vs, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, (1s-cis)- but generally known as abacavir, which bears us nih compound identifier 65140. abacavir most often appears in forms succinate and sulfate, and is sometimes combined with lamivudine and zidovudine. european medicines agency schedules abacavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07356mig. the term abacavir is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38). world health organization schedules abacavir in its anatomical therapeutic chemical (atc) classification. abacavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule abacavir under hs 29335995 and sitc 51576. as of q4 2014, abacavir remains the us fda preferred term for this commodity. abacavir bears us nlm identifiers umls id c0663655 and nci concept code c61523. smiles: occ1cc(n2c3nc(nc(nc4cc4)c3nc2)n)c=c1.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. alovudine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c10h13fn2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pg53r0dwdq, chemically known as thymidine, 3-deoxy-3-fluoro- but generally known as alovudine, which bears us nih compound identifier 33039. european medicines agency schedules alovudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05359mig. the term alovudine is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). alovudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alovudine under hs 29349990 and sitc 51579. as of q4 2014, alovudine remains the us fda preferred term for this commodity. alovudine bears us nlm identifiers umls id c0206795 and nci concept code c65226. smiles: cc1=cn(c(=o)nc1=o)c2cc(c(o2)co)f.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. ribavirin. this classification denotes an antiviral agent with the molecular formula c8h12n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49717awg6k, chemically known as 1,2,4-triazole-3-carboxamide, 1-.beta.-d-ribofuranosyl- but generally known as ribavirin, which bears us nih compound identifier 5064. european medicines agency schedules ribavirin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10297mig. the term ribavirin is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules ribavirin in its anatomical therapeutic chemical (atc) classification. ribavirin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ribavirin under hs 29349990 and sitc 51579. as of q4 2014, ribavirin remains the us fda preferred term for this commodity. ribavirin bears us nlm identifiers umls id c0035525 and nci concept code c807. smiles: o1c(c(o)c(o)c1n1nc(nc1)c(=o)n)co.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. telbivudine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c10h14n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2oc4hkd3sf, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-b-l-erythro-pentofuranosyl)-5-methyl- but generally known as telbivudine, which bears us nih compound identifier 159269. european medicines agency schedules telbivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25231. the term telbivudine is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules telbivudine in its anatomical therapeutic chemical (atc) classification. most nations schedule telbivudine under hs 29349990 and sitc 51579. as of q4 2014, telbivudine remains the us fda preferred term for this commodity. telbivudine bears us nlm identifiers umls id c1453933 and nci concept code c66584. smiles: cc1=cn(c(=o)nc1=o)c2cc(c(o2)co)o.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. abacavir succinate. this classification denotes a reverse transcriptase inhibitor, in succinate form, with the molecular formula c14h18n6o.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40fh6d8chk, chemically known as butanedoic acid, compd. with (1s,4r)-4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol (1:1) but more generally known as abacavir succinate, which bears us nih compound identifier 65139. the base compound, abacavir, also appears in sulfate form, and is sometimes combined with lamivudine and zidovudine. european medicines agency schedules abacavir succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25392. most nations, for tariff and trade purposes, schedule abacavir succinate under hs 29335995 and sitc 51576. as of q4 2014, abacavir succinate remains us fdas preferred term for this commodity. abacavir succinate bears us nlm identifiers umls id c2346706 and nci concept code c71608. smiles: c1nc2c(nc(nc2n1[c@@h]3c[c@@h](c=c3)co)n)nc4cc4.c(cc(=o)o)c(=o)o.. "
"antiviral nucleosides. antiviral drugs made from purine or pyrimidine bases attached to a ribose or deoxyribose.. abacavir sulfate. this classification denotes a reverse transcriptase inhibitor, in sulfate form, with the molecular formula 2c14h18n6o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j220t4j9q2, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, sulfate (salt)(2:1), (1s,4r)- but more generally known as abacavir sulfate, which bears us nih compound identifier 65141. the base compound, abacavir, also appears in succinate form, and is sometimes combined with lamivudine and zidovudine. european medicines agency schedules abacavir sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00231mig. most nations, for tariff and trade purposes, schedule abacavir sulfate under hs 29335995 and sitc 51576. as of q4 2014, abacavir sulfate remains us fdas preferred term for this commodity. abacavir sulfate bears us nlm identifiers umls id c0724515 and nci concept code c28804. smiles: c1nc2c(nc(nc2n1[c@@h]3c[c@@h](c=c3)co)n)nc4cc4.c1nc2c(nc(nc2n1[c@@h]3c[c@@h](c=c3)co)n)nc4cc4.os(=o)(=o)o.. "
"antiviral sulfur compounds. antiviral drugs made from inorganic or organic compounds that contain sulfur as an integral part of the molecule.. . "
"antiviral sulfur compounds. antiviral drugs made from inorganic or organic compounds that contain sulfur as an integral part of the molecule.. amidapsone. this classification denotes an antiviral agent and antimicrobial with the molecular formula c13h13n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8n5be1i42e, chemically known as urea, (p-sulfanilylphenyl)- (8ci) but generally known as amidapsone, which bears us nih compound identifier 66267. european medicines agency schedules amidapsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05426mig. the term amidapsone is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). amidapsone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amidapsone under hs 29309085 and sitc 51549. as of q4 2014, amidapsone remains the us fda preferred term for this commodity. amidapsone bears us nlm identifiers umls id c2346737 and nci concept code c73196. smiles: s(=o)(=o)(c1ccc(nc(=o)n)cc1)c1ccc(n)cc1.. "
"antiviral sulfur compounds. antiviral drugs made from inorganic or organic compounds that contain sulfur as an integral part of the molecule.. fomivirsen. this classification denotes an antisense agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3z6w3s36x5. european medicines agency schedules fomivirsen sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02253mig. fomivirsen sodium generally arises in the molecular formula c204h243n63o114p20s20.20na. the term fomivirsen sodium is a united states adopted name designation. most nations schedule fomivirsen under hs 29349990 and sitc 51579. as of q4 2014, fomivirsen remains the us fda preferred term for this commodity. smiles: s=p(oc1c(oc(n2cc(c(=o)[nh]c2=o)c)c1)cop(=s)(oc1c(oc(n2cc(c(=o)[nh]c2=o)c)c1)cop(=s)(oc1c(oc(n2cc(c(=o)[nh]c2=o)c)c1)cop(=s)(oc1c(oc(n2c3nc([nh]c(=o)c3nc2)n)c1)cop(=s)(oc1c(oc(n2ccc(nc2=o)n)c1)cop(=s)(oc1cc(oc1co)n1c2nc([nh]c(=o)c2nc1)n)o)o)o)o)o)(occ1oc(n2c3nc([nh]c(=o)c3nc2)n)cc1op(=s)(occ1oc(n2ccc(nc2=o)n)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2ccc(nc2=o)n)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2ccc(nc2=o)n)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2ccc(nc2=o)n)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2cc(c(=o)[nh]c2=o)c)cc1op(=s)(occ1oc(n2c3[nh]c(nc(=o)c3nc2)n)cc1op(=s)(occ1oc(n2ccc(nc2=o)n)cc1op(=s)(occ1oc(n2c3nc([nh]c(=o)c3nc2)n)cc1o)o)o)o)o)o)o)o)o)o)o)o)o)o)o)o.. "
"antiviral sulfur compounds. antiviral drugs made from inorganic or organic compounds that contain sulfur as an integral part of the molecule.. fomivirsen sodium. this classification denotes an antisense agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3z6w3s36x5. european medicines agency schedules fomivirsen sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02253mig. fomivirsen sodium generally arises in the molecular formula c204h243n63o114p20s20.20na. the term fomivirsen sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule fomivirsen sodium under hs 29349990 and sitc 51579. fomivirsen sodium bears us nlm identifiers umls id c0982166 and nci concept code c61770. smiles: as of q4 2014, fomivirsen sodium remains us fdas preferred term for this commodity.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. . "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. atazanavir. this classification denotes a protease inhibitor with the molecular formula c38h52n6o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qzu4h47a3s, chemically known as 2,5,6,10,13-pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3s,8s,9s,12s)- but generally known as atazanavir, which bears us nih compound identifier 148192. atazanavir most often comes in base and sulfate forms. european medicines agency schedules atazanavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16398mig. the term atazanavir is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules atazanavir in its anatomical therapeutic chemical (atc) classification. most nations schedule atazanavir under hs 29333999 and sitc 51574. as of q4 2014, atazanavir remains the us fda preferred term for this commodity. atazanavir bears us nlm identifiers umls id c1145759 and nci concept code c66872. smiles: oc(c(nc(=o)c(nc(=o)oc)c(c)(c)c)cc1ccccc1)cn(nc(=o)c(nc(=o)oc)c(c)(c)c)cc1ccc(cc1)c1ncccc1.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. enfuvirtide. this classification denotes an anti-hiv agent with the molecular formula c204h301n51o64, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19owo1t3ze, chemically known as l-phenylalaninamide, n-acetyl-l-tyrosyl-l-threonyl-l-seryl-l-leucyl-l-isoleucyl-l-histidyl-l-seryl-l-leucyl-l-isoleucyl-l-alpha-glutamyl-l-alpha-glutamyl-l-seryl-l-glutaminyl-l-asparaginyl-l-glutaminyl-l-glutaminyl-l-alpha-glutamyl-l-lysyl-l-asparaginyl-l-alpha-glutamyl-l-glutaminyl-l-alpha-glutamyl-l-leucyl-l-leucyl-l-alpha-glutamyl-l-leucyl-l-alpha-aspartyl-l-lysyl-l-tryptophyl-l-alanyl-l-seryl-l-leucyl-l-tryptophyl-l-asparaginyl-l-tryptophyl- but generally known as enfuvirtide, which bears us nih compound identifier 16130199. european medicines agency schedules enfuvirtide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12496mig. the term enfuvirtide is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). world health organization schedules enfuvirtide in its anatomical therapeutic chemical (atc) classification. most nations schedule enfuvirtide under hs 29332990 and sitc 51573. as of q4 2014, enfuvirtide remains the us fda preferred term for this commodity. enfuvirtide bears us nlm identifiers umls id c0537439 and nci concept code c2105. smiles: o=c(nc(c(cc)c)c(=o)nc(ccc(=o)o)c(=o)nc(ccc(=o)o)c(=o)nc(co)c(=o)nc(ccc(=o)n)c(=o)nc(c(=o)nc(ccc(=o)n)c(=o)nc(c(=o)nc(c(=o)nc(ccccn)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(cc(c)c)c(=o)nc(ccc(=o)o)c(=o)nc(cc(c)c)c(=o)nc(c(=o)nc(ccccn)c(=o)nc(cc1c2c([nh]c1)cccc2)c(=o)nc(c(=o)nc(c(=o)nc(cc(c)c)c(=o)nc(cc1c2c([nh]c1)cccc2)c(=o)nc(cc(=o)n)c(=o)nc(cc1c2c([nh]c1)cccc2)c(=o)nc(cc1ccccc1)c(=o)n)co)c)cc(=o)o)ccc(=o)o)ccc(=o)n)ccc(=o)o)cc(=o)n)ccc(=o)o)ccc(=o)n)cc(=o)n)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c)cc1ccc(o)cc1)c(o)c)co)cc(c)c)c(cc)c)cc1[nh]cnc1)co)cc(c)c.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. telaprevir. this classification denotes an antiviral agent with the molecular formula c36h53n7o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 655m5o3w0u. european medicines agency schedules telaprevir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31651. the term telaprevir is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56. ). most nations schedule telaprevir under hs 29339990 and sitc 51577. as of q4 2014, telaprevir remains the us fda preferred term for this commodity. telaprevir bears us nlm identifiers umls id c1876229 and nci concept code c81603. smiles: cccc(c(=o)c(=o)nc1cc1)nc(=o)c2c3cccc3cn2c(=o)c(c(c)(c)c)nc(=o)c(c4ccccc4)nc(=o)c5=nc=cn=c5.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. boceprevir. this classification denotes a protease inhibitor and antiviral with the molecular formula c27h45n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89bt58kelh, chemically known as (1r,2s,5s)-n-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2s)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide but generally known as boceprevir, which bears us nih compound identifier 10324367. boceprevir most often comes in base and sulfate forms. european medicines agency schedules boceprevir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31579. the term boceprevir is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 1, 2008, list 59.). as of q4 2014, boceprevir remains the us fda preferred term for this commodity. smiles: cc1(c2c1c(n(c2)c(=o)c(c(c)(c)c)nc(=o)nc(c)(c)c)c(=o)nc(cc3ccc3)c(=o)c(=o)n)c.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon alfa-2a. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47rrr83sk7. european medicines agency schedules interferon alfa-2a in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12447mig. as of q4 2014, interferon alfa-2a remains the us fda preferred term for this commodity. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon alfa-2b. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43k1w2t1m6, also known as human leucocyte clone pm21 protein moiety reduced. european medicines agency schedules interferon alfa-2a in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12521mig. as of q4 2014, interferon alfa-2b remains the us fda preferred term for this commodity. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon alfacon-1. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56588op40d. european medicines agency schedules interferon alfa-2a in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08199mig. as of q4 2014, interferon alfacon-1 remains the us fda preferred term for this commodity. interferon alfacon-1 bears us nlm identifiers umls id c0164613 and nci concept code c1766. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon alfa-n1. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47bpr3v3mp. european medicines agency schedules interferon alfa-n1 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20625. as of q4 2014, interferon alfa-n1 remains the us fda preferred term for this commodity. interferon alfa-n1 bears us nlm identifiers umls id c0699817 and nci concept code c2220. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon beta-1a. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xro4566q4r. european medicines agency schedules interferon alfa-n1 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12440mig. as of q4 2014, interferon beta-1a remains the us fda preferred term for this commodity. interferon beta-1a bears us nlm identifiers umls id c0982234 and nci concept code c1823. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon beta-1b. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ttd90r31wz. european medicines agency schedules interferon alfa-n1 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12432mig. as of q4 2014, interferon beta-1b remains the us fda preferred term for this commodity. interferon beta-1b bears us nlm identifiers umls id c0244714 and nci concept code c2221. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. interferon gamma-1b. this classification denotes an interferon, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21k6m2i7ag. european medicines agency schedules interferon alfa-n1 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12076mig. as of q4 2014, interferon gamma-1b remains the us fda preferred term for this commodity. interferon gamma-1b bears us nlm identifiers umls id c1579322 and nci concept code c100089. smiles: none.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. peginterferon alfa-2b. this classification denotes a pegylated interferon alfa with the molecular formula c2h4no2(c2h4o)n, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier g8rgg88b68. european medicines agency schedules peginterferon alfa-2b in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12549mig. the term peginterferon alfa-2b is an international non-proprietary name or inn.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. atazanavir sulfate. this classification denotes a protease inhibitor with the molecular formula c38h52n6o7.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4mt4vie29p, chemically known as 2,5,6,10,13-pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3s,8s,9s,12s)-, sulfate (1:1) (salt) but more generally known as atazanavir sulfate, which bears us nih compound identifier 158550. european medicines agency schedules atazanavir sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20595. most nations, for tariff and trade purposes, schedule atazanavir sulfate under hs 29333999 and sitc 51574. as of q4 2014, atazanavir sulfate remains us fdas preferred term for this commodity. atazanavir sulfate bears us nlm identifiers umls id c1176383 and nci concept code c28835. smiles: cc(c)(c)[c@@h](c(=o)n[c@@h](cc1ccccc1)[c@h](cn(cc2ccc(cc2)c3ccccn3)nc(=o)[c@h](c(c)(c)c)nc(=o)oc)o)nc(=o)oc.os(=o)(=o)o.. "
"antiviral peptides. antiviral drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures.. atazanavir sulphate. this classification denotes a protease inhibitor with the molecular formula c38h52n6o7.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4mt4vie29p, chemically known as 2,5,6,10,13-pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3s,8s,9s,12s)-, sulfate (1:1) (salt) but more generally known as atazanavir sulfate, which bears us nih compound identifier 158550. european medicines agency schedules atazanavir sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20595. most nations, for tariff and trade purposes, schedule atazanavir sulphate under hs 29333999. smiles: cc(c)(c)[c@@h](c(=o)n[c@@h](cc1ccccc1)[c@h](cn(cc2ccc(cc2)c3ccccn3)nc(=o)[c@h](c(c)(c)c)nc(=o)oc)o)nc(=o)oc.os(=o)(=o)o.. "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. . "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. aranotin. this classification denotes an antiviral agent with the molecular formula c20h18n2o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h56ckb2ffv, chemically known as 5,5a,13,13a-tetrahydro-5,13-dihydroxy-8h,16h-7a,15a-epidithio-7h,15h-bisoxepino(3,4:4,5)pyrrolo(1,2-a:1,2-d)pyrazine-7,15-dione 5-acetate but generally known as aranotin, which bears us nih compound identifier 29844. european medicines agency schedules aranotin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05551mig. the term aranotin is an international non-proprietary name. aranotin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aranotin under hs 29349990 and sitc 51579. as of q4 2014, aranotin remains the us fda preferred term for this commodity. aranotin bears us nlm identifiers umls id c0052306 and nci concept code c81609. smiles: s1sc23n(c4c(=coc=cc4o)c2)c(=o)c21n(c1c(=coc=cc1oc(=o)c)c2)c3=o.. "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. atevirdine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c21h25n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, n24015wc6d chemically known as piperazine, 1-(3-(ethylamino)-2-pyridinyl)-4-((5-methoxy-1h-indol-2-yl)carbonyl)-, monomethanesulfonate but generally known as atevirdine, which bears us nih compound identifier 60848. european medicines agency schedules atevirdine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05591mig. the term atevirdine is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34. ). most nations schedule atevirdine under hs 29335995 and sitc 51576. as of q4 2014, atevirdine remains the us fda preferred term for this commodity. atevirdine bears us nlm identifiers umls id c0210243 and nci concept code c73840. smiles: ccnc1=c(n=cc=c1)n2ccn(cc2)c(=o)c3=cc4=c(n3)c=cc(=c4)oc.. "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. delavirdine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c22h28n6o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dol5f9jd3e, chemically known as piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1h-indol-2-yl)carbonyl)- but generally known as delavirdine, which bears us nih compound identifier 5625. european medicines agency schedules delavirdine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06949mig. the term delavirdine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules delavirdine in its anatomical therapeutic chemical (atc) classification. delavirdine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule delavirdine under hs 29350090 and sitc 51580. as of q4 2014, delavirdine remains the us fda preferred term for this commodity. delavirdine bears us nlm identifiers umls id c0288165 and nci concept code c65366. smiles: s(=o)(=o)(nc1cc2cc([nh]c2cc1)c(=o)n1ccn(cc1)c1ncccc1nc(c)c)c.. "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. atevirdine mesilate or mesylate. this classification denotes a reverse transcriptase inhibitor with the molecular formula c21h25n5o2.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a948d8673w. the term atevirdine mesilate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule atevirdine mesylate under hs 29335995. as of q4 2014, atevirdine mesylate remains us fdas preferred term for this commodity. atevirdine mesylate bears us nlm identifiers umls id c0210242 and nci concept code c73148. smiles: ccnc1cccnc1n2ccn(cc2)c(=o)c3cc4cc(ccc4[nh]3)oc.cs(=o)(=o)o.. "
"antiviral piperazines. antiviral drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. delavirdine mesilate or mesylate. this classification denotes a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 421105krqe. european medicines agency schedules delavirdine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01575mig. delavirdine mesylate generally arises in the molecular formula c22h28n6o3s.ch4o3s. the term delavirdine mesylate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule delavirdine mesylate under hs 29350090 and sitc 51580. as of q4 2014, delavirdine mesylate remains us fdas preferred term for this commodity. delavirdine mesylate bears us nlm identifiers umls id c0543492 and nci concept code c28974. smiles: cc(c)nc1cccnc1n2ccn(cc2)c(=o)c3cc4cc(ccc4[nh]3)ns(=o)(=o)c.cs(=o)(=o)o.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. . "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. didanosine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c10h12n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k3gdh6oh08, chemically known as 2,3-dideoxyinosine & scd4(soluble recombinant protein) but generally known as didanosine, which bears us nih compound identifier 50599. european medicines agency schedules didanosine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07104mig. the term didanosine is an international non-proprietary name. world health organization schedules didanosine in its anatomical therapeutic chemical (atc) classification. didanosine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule didanosine under hs 29349990 and sitc 51579. as of q4 2014, didanosine remains the us fda preferred term for this commodity. didanosine bears us nlm identifiers umls id c0012133 and nci concept code c431. smiles: c1c[c@@h](o[c@@h]1co)n2c=nc3=c2nc=nc3=o.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. famciclovir. this classification denotes a purine antagonist and antiviral agent with the molecular formula c14h19n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qic03ani02, chemically known as 1,3-propanediol, 2-(2-(2-amino-9h-purin-9-yl)ethyl)-, diacetate (ester) but generally known as famciclovir, which bears us nih compound identifier 3324. european medicines agency schedules famciclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07501mig. the term famciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules famciclovir in its anatomical therapeutic chemical (atc) classification. famciclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule famciclovir under hs 29335995 and sitc 51576. as of q4 2014, famciclovir remains the us fda preferred term for this commodity. famciclovir bears us nlm identifiers umls id c0209227 and nci concept code c29044. smiles: o(cc(ccn1c2nc(ncc2nc1)n)coc(=o)c)c(=o)c.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. inosine pranobex. this classification denotes an immunostimulant with the molecular formula c10h12n4o5.3c9h9no3.3c5h13no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w1so0v223f, chemically known as p-acetamidobenzoic salt of n,n-dimethylamino-2-propanol & inosine (3:1) np 113 but generally known as inosine pranobex, which bears us nih compound identifier 37510. european medicines agency schedules inosine pranobex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14214mig. world health organization schedules inosine pranobex in its anatomical therapeutic chemical (atc) classification. most nations schedule inosine pranobex under hs 29349990 and sitc 51579. as of q4 2014, inosine pranobex remains the us fda preferred term for this commodity. inosine pranobex bears us nlm identifiers umls id c0022230 and nci concept code c601. smiles: cc1=cn(c(=o)nc1=o)c2cc(c(o2)co)n=[n+]=[n-].cc(cn(c)c)o.cc(=o)nc1=cc=c(c=c1)c(=o)o.c1=nc(=o)c2=c(n1)n(c=n2)c3c(c(c(o3)co)o)o.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. vidarabine. this classification denotes a purine antagonist and antiviral agent with the molecular formula c10h13n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xqd2mew34, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but generally known as vidarabine, which bears us nih compound identifier 191. european medicines agency schedules vidarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00047mig. the term vidarabine is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules vidarabine in its anatomical therapeutic chemical (atc) classification. vidarabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vidarabine under hs 29349990 and sitc 51579. as of q4 2014, vidarabine remains the us fda preferred term for this commodity. vidarabine bears us nlm identifiers umls id c0042646 and nci concept code c929. smiles: c1=nc2=c(c(=n1)n)n=cn2c3c(c(c(o3)co)o)o.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. vidarabine anhydrous. this classification denotes a purine antagonist and antiviral agent with the molecular formula c10h13n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xqd2mew34, chemically known as vidarabine, anhydrous, but more generally known as vidarabine anhydrous, which bears us nih compound identifier 21704. european medicines agency schedules vidarabine anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00047mig. most nations, for tariff purposes, schedule vidarabine anhydrous under hs 29349990. vidarabine anhydrous bears us nlm identifiers umls id c2700247 and nci concept code c77393. smiles: c1nc(c2c(n1)n(cn2)[c@h]3[c@h]([c@@h]([c@h](o3)co)o)o)n.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. vidarabine phosphate. this classification denotes the phosphate form of a purine antagonist and antiviral agent with the molecular formula c10h13n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xqd2mew34, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but more generally known as vidarabine, which bears us nih compound identifier 191. european medicines agency schedules vidarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00047mig. the term vidarabine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules vidarabine in its anatomical therapeutic chemical (atc) classification. vidarabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule vidarabine phosphate under hs 29349990 and sitc 51579. as of q4 2014, vidarabine phosphate remains us fdas preferred term for this commodity. vidarabine phosphate bears us nlm identifiers umls id c0003674 and nci concept code c90789. smiles: c1nc(c2c(n1)n(cn2)[c@h]3[c@h]([c@@h]([c@h](o3)cop(=o)(o)o)o)o)n.. "
"antiviral purines. antiviral drugs made from a series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases.. vidarabine sodium phosphate. this classification denotes an antiviral agent with the molecular structure c10h12n5o7p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, zec0wcc7ua chemically known as 9-.beta.-d-arabinofuranosyladenine 5-(dihydrogen phosphate), disodium salt, but more commonly known as vidarabine sodium phosphate, which bears us nih compound identifier 224. european medicines agency schedules vidarabine sodium phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05095mig. most nations, for tariff and trade purposes, schedule vidarabine sodium phosphate under hs 29349990 and sitc 51579. as of q4 2014, vidarabine sodium phosphate remains us fdas preferred term for this commodity. vidarabine sodium phosphate bears us nlm identifiers umls id c0771597 and nci concept code c95911. smiles: c1nc(c2c(n1)n(cn2)[c@h]3[c@h]([c@@h]([c@h](o3)cop(=o)([o-])[o-])o)o)n.[na+].[na+].. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. . "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. indinavir. this classification denotes a protease inhibitor and anti-hiv agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5w6ya9pkkh. european medicines agency schedules indinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08174mig. indinavir generally arises in the molecular formula c36h47n5o4. the term indinavir is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36.) indinavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule indinavir under hs 29335995 and sitc 51576. as of q4 2014, indinavir remains the us fda preferred term for this commodity. indinavir bears us nlm identifiers umls id c0376637 and nci concept code c66877. smiles: cc(c)(c)nc(=o)[c@@h]1cn(ccn1c[c@h](c[c@@h](cc2ccccc2)c(=o)n[c@h]3c4ccccc4c[c@h]3o)o)cc5cccnc5.o.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. nevirapine. this classification denotes a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99dk7fvk1h. european medicines agency schedules nevirapine, anhydrous in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25191. nevirapine generally arises in the molecular formula c15h14n4o. the term nevirapine is a european pharmacopoeia designation. nevirapine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nevirapine under hs 29339940 and sitc 51577. as of q4 2014, nevirapine remains the us fda preferred term for this commodity. nevirapine bears us nlm identifiers umls id c0132326 and nci concept code c29277. smiles: o=c1[nh]c2c(n(c3cc3)c3ncccc13)nccc2c.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. tipranavir. this classification denotes a protease inhibitor with the molecular formula c31h33f3n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zzt404xd09, chemically known as 2-pyridinesulfonamide, n-(3-((1r)-1-((6r)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2h-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)- but generally known as tipranavir, which bears us nih compound identifier 65027. european medicines agency schedules tipranavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04883mig. the term tipranavir is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules tipranavir in its anatomical therapeutic chemical (atc) classification. most nations schedule tipranavir under hs 29350090 and sitc 51580. as of q4 2014, tipranavir remains the us fda preferred term for this commodity. tipranavir bears us nlm identifiers umls id c0663733 and nci concept code c66603. smiles: s(=o)(=o)(nc1cc(c(c2=c(oc(cc2=o)(ccc2ccccc2)ccc)o)cc)ccc1)c1ncc(cc1)c(f)(f)f.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. stavudine or stavidine. this classification denotes a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bo9le4qfzf. european medicines agency schedules stavudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10642mig. stavudine generally arises in the molecular formula c10h12n2o4. the term stavudine is an international non-proprietary name or inn. stavudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. stavudine or stavidine bears us nlm identifiers umls id c0164662 and nci concept code c1428. smiles: cc1=cn(c(=o)nc1=o)c2c=cc(o2)co.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. stavudine and lamivudine and nevirapine. this classification denotes a combination drug for treatment of hiv. the first component of this combination drug is a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bo9le4qfzf. european medicines agency schedules stavudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10642mig. stavudine generally arises in the molecular formula c10h12n2o4. the term stavudine is an international non-proprietary name or inn. stavudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=cn(c(=o)nc1=o)c2c=cc(o2)co. the second component of this drug is a reverse transcriptase inhibitor with the molecular formula c8h11n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2t8q726o95, chemically known as 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone but generally known as lamivudine, which bears us nih compound identifier 60825. european medicines agency schedules lamivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08392mig. the term lamivudine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules lamivudine in its anatomical therapeutic chemical (atc) classification. lamivudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. the third component of this combination drug is a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99dk7fvk1h. european medicines agency schedules nevirapine, anhydrous in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25191. nevirapine generally arises in the molecular formula c15h14n4o. the term nevirapine is a european pharmacopoeia designation. nevirapine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. indinavir sulfate. this classification denotes a protease inhibitor and anti-hiv agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5w6ya9pkkh. european medicines agency schedules indinavir sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02666mig. indinavir sulfate generally arises in the molecular formula c36h47n5o4.h2o4s. the term indinavir sulfate is a european medicines agency european public assessment report system designation. most nations, for tariff and trade purposes, schedule indinavir sulfate under hs 29335995 and sitc 51576. as of q4 2014, indinavir sulfate remains us fdas preferred term for this commodity. indinavir sulfate bears us nlm identifiers umls id c0700483 and nci concept code c1662. smiles: cc(c)(c)nc(=o)[c@@h]1cn(ccn1c[c@h](c[c@@h](cc2ccccc2)c(=o)n[c@h]3c4ccccc4c[c@h]3o)o)cc5cccnc5.os(=o)(=o)o.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. indinavir sulphate. this classification denotes a protease inhibitor and anti-hiv agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5w6ya9pkkh. european medicines agency schedules indinavir sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02666mig. indinavir sulphate generally arises in the molecular formula c36h47n5o4.h2o4s. the term indinavir sulphate is a european medicines agency european public assessment report system designation. most nations, for tariff and trade purposes, schedule indinavir sulphate under hs 29335995. smiles: cc(c)(c)nc(=o)[c@@h]1cn(ccn1c[c@h](c[c@@h](cc2ccccc2)c(=o)n[c@h]3c4ccccc4c[c@h]3o)o)cc5cccnc5.os(=o)(=o)o.. "
"antiviral pyridines. antiviral drugs made from compounds with a six membered aromatic ring containing nitrogen.. nevirapine hemihydrate. this classification denotes a reverse transcriptase inhibitor with the molecular formula 2c15h14n4o.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b7xf2td73c. european medicines agency schedules nevirapine hemihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub34149. most nations, for tariff and trade purposes, schedule nevirapine hemihydrate under hs 29339940 and sitc 51577. as of q4 2014, nevirapine hemihydrate remains us fdas preferred term for this commodity. smiles: cc1ccnc2c1nc(=o)c3cccnc3n2c4cc4.cc1ccnc2c1nc(=o)c3cccnc3n2c4cc4.o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. . "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. idoxuridine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h11in2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lgp81v5245, chemically known as uridine, 5-iodo-2-deoxy- but generally known as idoxuridine, which bears us nih compound identifier 3687. european medicines agency schedules idoxuridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08117mig. the term idoxuridine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules idoxuridine in its anatomical therapeutic chemical (atc) classification. idoxuridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule idoxuridine under hs 29349990 and sitc 51579. as of q4 2014, idoxuridine remains the us fda preferred term for this commodity. idoxuridine bears us nlm identifiers umls id c0020811 and nci concept code c563. smiles: ic1cn(c2oc(c(o)c2)co)c(=o)[nh]c1=o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. brivudine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c11h13brn2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2m3055079h, chemically known as uridine, 5-(2-bromovinyl)-2-deoxy-, (e)- but generally known as brivudine, which bears us nih compound identifier 446727. european medicines agency schedules brivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05893mig. the term brivudine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules brivudine in its anatomical therapeutic chemical (atc) classification. brivudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule brivudine under hs 29349990 and sitc 51579. as of q4 2014, brivudine remains the us fda preferred term for this commodity. brivudine bears us nlm identifiers umls id c0163272 and nci concept code c67088. smiles: c1c(c(oc1n2c=c(c(=o)nc2=o)c=cbr)co)o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. clevudine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c10h13fn2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier in51mvp5f1, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl)-5-methyl- but generally known as clevudine, which bears us nih compound identifier 73115. european medicines agency schedules clevudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06656mig. the term clevudine is an international non-proprietary name. world health organization schedules clevudine in its anatomical therapeutic chemical (atc) classification. clevudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clevudine under hs 29349990 and sitc 51579. as of q4 2014, clevudine remains the us fda preferred term for this commodity. clevudine bears us nlm identifiers umls id c0045212 and nci concept code c95210. smiles: cc1=cn(c(=o)nc1=o)c2c(c(c(o2)co)o)f.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. emivirine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c17h22n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x87g8ix72o, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)- but generally known as emivirine, which bears us nih compound identifier 65013. european medicines agency schedules emivirine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01880mig. the term emivirine is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule emivirine under hs 29335995 and sitc 51576. as of q4 2014, emivirine remains the us fda preferred term for this commodity. emivirine bears us nlm identifiers umls id c0248121 and nci concept code c73147. smiles: o(cn1c(c(c(c)c)c(=o)[nh]c1=o)cc1ccccc1)cc.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. emtricitabine. this classification denotes a reverse transcriptase inhibitor and pyrimidine antagonist with the molecular formula c8h10fn3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g70b4etf4s, chemically known as 5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine but generally known as emtricitabine, which bears us nih compound identifier 60877. european medicines agency schedules emtricitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01882mig. the term emtricitabine is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules emtricitabine in its anatomical therapeutic chemical (atc) classification. most nations schedule emtricitabine under hs 29349990 and sitc 51579. as of q4 2014, emtricitabine remains the us fda preferred term for this commodity. emtricitabine bears us nlm identifiers umls id c0909839 and nci concept code c47509. smiles: s1cc(oc1co)n1cc(f)c(nc1=o)n.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. epervudine. this classification denotes a pyrimidine antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3g05ph9fas. european medicines agency schedules epervudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06561mig. epervudine generally arises in the molecular formula c12h18n2o5. the term epervudine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30.) epervudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epervudine under hs 29349990 and sitc 51579. as of q4 2014, epervudine remains the us fda preferred term for this commodity. epervudine bears us nlm identifiers umls id c2700002 and nci concept code c76916. smiles: cc(c)c1=cn(c(=o)nc1=o)c2cc(c(o2)co)o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. fiacitabine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h11fin3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4058h365zb, chemically known as 2(1h)-pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fiacitabine, which bears us nih compound identifier 50312. european medicines agency schedules fiacitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07621mig. the term fiacitabine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). fiacitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fiacitabine under hs 29349990 and sitc 51579. as of q4 2014, fiacitabine remains the us fda preferred term for this commodity. fiacitabine bears us nlm identifiers umls id c0045211 and nci concept code c73202. smiles: ic1cn(c2oc(c(o)c2f)co)c(=o)nc1n.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. fialuridine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h10fin2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 53t7in77lc, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-iodo- but generally known as fialuridine, which bears us nih compound identifier 50313. european medicines agency schedules fialuridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07622mig. the term fialuridine is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). fialuridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fialuridine under hs 29349990 and sitc 51579. as of q4 2014, fialuridine remains the us fda preferred term for this commodity. fialuridine bears us nlm identifiers umls id c0208078 and nci concept code c73197. smiles: ic1cn(c2oc(c(o)c2f)co)c(=o)[nh]c1=o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. ibacitabine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h12in3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3ek8532dzv, chemically known as cytidine, 2-deoxy-5-iodo- (8ci)(9ci) but generally known as ibacitabine, which bears us nih compound identifier 65050. european medicines agency schedules ibacitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08090mig. the term ibacitabine is an international non-proprietary name. world health organization schedules ibacitabine in its anatomical therapeutic chemical (atc) classification. ibacitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ibacitabine under hs 29349990 and sitc 51579. as of q4 2014, ibacitabine remains the us fda preferred term for this commodity. ibacitabine bears us nlm identifiers umls id c0049263 and nci concept code c83771. smiles: ic1cn(c2oc(c(o)c2)co)c(=o)nc1n.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. lamivudine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c8h11n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2t8q726o95, chemically known as 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone but generally known as lamivudine, which bears us nih compound identifier 60825. european medicines agency schedules lamivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08392mig. the term lamivudine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules lamivudine in its anatomical therapeutic chemical (atc) classification. lamivudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lamivudine under hs 29349990 and sitc 51579. as of q4 2014, lamivudine remains the us fda preferred term for this commodity. lamivudine bears us nlm identifiers umls id c0209738 and nci concept code c1471. smiles: c1cn(c(=o)nc1n)[c@@h]2cs[c@@h](o2)co.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. lopinavir. this classification denotes a protease inhibitor with the molecular formula c37h48n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2494g1jf75, chemically known as 1(2h)-pyrimidineacetamide, n-((1s,3s,4s)-4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahyrdo-alpha-1-methylethyl)-2-oxo-, (alphas)- but generally known as lopinavir, which bears us nih compound identifier 92727. european medicines agency schedules lopinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02970mig. the term lopinavir is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules lopinavir in its anatomical therapeutic chemical (atc) classification. most nations schedule lopinavir under hs 29335995 and sitc 51576. as of q4 2014, lopinavir remains the us fda preferred term for this commodity. lopinavir bears us nlm identifiers umls id c0674432 and nci concept code c2095. smiles: oc(cc(nc(=o)c(n1cccnc1=o)c(c)c)cc1ccccc1)c(nc(=o)coc1c(cccc1c)c)cc1ccccc1.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. navuridine. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h11n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ps28w65479. the term navuridine is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46. ). most nations schedule navuridine under hs 29349990 and sitc 51579. as of q4 2014, navuridine remains the us fda preferred term for this commodity. navuridine bears us nlm identifiers umls id c0046786 and nci concept code c83920. smiles: c1c(c(oc1n2c=cc(=o)nc2=o)co)n=[n+]=[n-].. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. sorivudine. this classification denotes a dihydropyrimidine dehydrogenase inhibitor with the molecular formula c11h13brn2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c7voz162lv, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-beta-d-arabinofuranosyl-5-(2-bromoethenyl)-, (e)- but generally known as sorivudine, which bears us nih compound identifier 5282192. european medicines agency schedules sorivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10605mig. the term sorivudine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). sorivudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sorivudine under hs 29349990 and sitc 51579. as of q4 2014, sorivudine remains the us fda preferred term for this commodity. sorivudine bears us nlm identifiers umls id c0207628 and nci concept code c1460. smiles: c1=c(c(=o)nc(=o)n1c2c(c(c(o2)co)o)o)c=cbr.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. zalcitabine. this classification denotes a pyrimidine antagonist with the molecular formula c9h13n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6l3xt8cb3i, chemically known as dideoxycytidine but generally known as zalcitabine, which bears us nih compound identifier 24066. european medicines agency schedules zalcitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00130mig. the term zalcitabine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules zalcitabine in its anatomical therapeutic chemical (atc) classification. zalcitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zalcitabine under hs 29349990 and sitc 51579. as of q4 2014, zalcitabine remains the us fda preferred term for this commodity. zalcitabine bears us nlm identifiers umls id c0012132 and nci concept code c430. smiles: o1c(n2ccc(nc2=o)n)ccc1co.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. azidothymidine or zidovudine. this classification denotes a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4b9xt59t7s. european medicines agency schedules zidovudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00153mig. zidovudine generally arises in the molecular formula c10h13n5o4. the term zidovudine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) zidovudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. azidothymidine or zidovudine bears us nlm identifiers umls id c0043474 and nci concept code c947. smiles: cc1=cn(c(=o)nc1=o)c2cc(c(o2)co)n=[n+]=[n-].. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. idoxuridine monohydrate. this classification denotes a pyrimidine antagonist and antiviral agent with the molecular formula c9h11in2o5.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7e78kl7pvw, chemically known as uridine, 2-deoxy-5-iodo-, monohydrate, but more generally known as idoxuridine monohydrate, which bears us nih compound identifier 28330. european medicines agency schedules idoxuridine monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08117mig. most nations, for tariff purposes, schedule idoxuridine monohydrate under hs 29349990. smiles: c1c(c(=o)[nh]c(=o)n1[c@h]2c[c@@h]([c@h](o2)co)o)i.o.. "
"antiviral pyrimidines. antiviral drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. lamivudine sulfoxide. this classification denotes a reverse transcriptase inhibitor with the molecular formula c8h11n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l0eh965x85, chemically known as lamivudine sulfoxide, (3rs)-, but more generally known as lamivudine sulfoxide, which bears us nih compound identifier 3081342. european medicines agency schedules lamivudine sulfoxide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08392mig. most nations, for tariff purposes, schedule lamivudine sulfoxide under hs 29349990. smiles: c1cn(c(=o)nc1n)[c@@h]2c[s+]([c@@h](o2)co)[o-].. "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. . "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. raltegravir. this classification denotes an antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 22vkv8053u. european medicines agency schedules raltegravir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25667. raltegravir generally arises in the molecular formula c20h21fn6o5. the term raltegravir is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 1, 2008, list 59.) as of q4 2014, raltegravir remains the us fda preferred term for this commodity. raltegravir bears us nlm identifiers umls id c1871526 and nci concept code c72837. smiles: cc1=nn=c(o1)c(=o)nc(c)(c)c2=nc(=c(c(=o)n2c)o)c(=o)ncc3=cc=c(c=c3)f.. "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. palinavir. this classification denotes a protease inhibitor with the molecular formula c41h52n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 632s1wu9z2, chemically known as 2-quinolinecarboxamide, n-(1-(((3-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(4-pyridinylmethoxy)-1-piperidinyl)-2-hydroxy-1-(phenylmethyl)propyl)amino)carbonyl)-2-methylpropyl)-, (2s-(1(1r*(r*),2s*),2alpha,4alpha))- but generally known as palinavir, which bears us nih compound identifier 72981. european medicines agency schedules palinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09589mig. the term palinavir is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). palinavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule palinavir under hs 29334910 and sitc 51575. as of q4 2014, palinavir remains the us fda preferred term for this commodity. palinavir bears us nlm identifiers umls id c0663725 and nci concept code c66292. smiles: o(c1cc(n(cc1)cc(o)c(nc(=o)c(nc(=o)c1nc2c(cc1)cccc2)c(c)c)cc1ccccc1)c(=o)nc(c)(c)c)cc1ccncc1.. "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. ritonavir. this classification denotes a protease inhibitor with the molecular formula c37h48n6o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o3j8g9o825, chemically known as 2,4,7,12-tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5s-(5r*,8r*,10r*,11r*))- but generally known as ritonavir, which bears us nih compound identifier 60954. european medicines agency schedules ritonavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10342mig. the term ritonavir is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules ritonavir in its anatomical therapeutic chemical (atc) classification. most nations schedule ritonavir under hs 29341000 and sitc 51579. as of q4 2014, ritonavir remains the us fda preferred term for this commodity. ritonavir bears us nlm identifiers umls id c0292818 and nci concept code c1609. smiles: s1c(nc(cn(c(=o)nc(c(c)c)c(=o)nc(cc(o)c(nc(=o)occ2scnc2)cc2ccccc2)cc2ccccc2)c)c1)c(c)c.. "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. dolutegravir. dolutegravir is used to treat human immunodeficiency virus (hiv) infection.. "
"antiviral pyrrolidinones and quinolines and thiazoles. this classification denotes antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles. elvitegravir. a type of human immunodeficiency virus type 1 (hiv-1) integrasestrand transfer inhibitor used in combination with an hiv proteaseinhibitor coadministered with ritonavir and with other antiretroviraldrug(s) indicated for the treatment of hiv-1 infection in antiretroviraltreatment-experienced adults.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. . "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. xenazoic acid. this classification denotes an antiviral agent with the molecular formula c23h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kdu8vh09o8, chemically known as benzoic acid, p-(alpha-ethoxy-p-phenylphenacylamino)- but generally known as xenazoic acid, which bears us nih compound identifier 239062. european medicines agency schedules xenazoic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00101mig. the term xenazoic acid is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). most nations schedule xenazoic acid under hs 29225000 and sitc 51467. as of q4 2014, xenazoic acid remains the us fda preferred term for this commodity. xenazoic acid bears us nlm identifiers umls id c1883571 and nci concept code c66662. smiles: o(c(nc1ccc(cc1)c(=o)o)c(=o)c1ccc(cc1)c1ccccc1)cc.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. edoxudine. this classification denotes an antiviral agent with the molecular formula c11h16n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 15zqm81y3r, chemically known as uridine, 2-deoxy-5-ethyl- but generally known as edoxudine, which bears us nih compound identifier 1814. european medicines agency schedules edoxudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06460mig. the term edoxudine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules edoxudine in its anatomical therapeutic chemical (atc) classification. edoxudine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule edoxudine under hs 29349990 and sitc 51579. as of q4 2014, edoxudine remains the us fda preferred term for this commodity. edoxudine bears us nlm identifiers umls id c0115510 and nci concept code c87662. smiles: ccc1=cn(c(=o)nc1=o)c2cc(c(o2)co)o.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. memotine. this classification denotes an antiviral agent with the molecular formula c17h17no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42bhh3wp14, chemically known as 1-[(4-methoxyphenoxy)methyl]-3,4-dihydroisoquinoline but generally known as memotine, which bears us nih compound identifier 25350. most nations schedule memotine under hs 29334990 and sitc 51575. as of q4 2014, memotine remains the us fda preferred term for this commodity. memotine bears us nlm identifiers umls id c2981324 and nci concept code c87664. smiles: coc1=cc=c(c=c1)occ2=nccc3=cc=cc=c32.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. mozenavir. this classification denotes a protease inhibitor with the molecular formula c33h36n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 64oo8946er. the term mozenavir is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46. ). most nations schedule mozenavir under hs 29339940 and sitc 51577. as of q4 2014, mozenavir remains the us fda preferred term for this commodity. mozenavir bears us nlm identifiers umls id c0390428 and nci concept code c77390. smiles: c1=cc=c(c=c1)cc2c(c(c(n(c(=o)n2cc3=cc(=cc=c3)n)cc4=cc(=cc=c4)n)cc5=cc=cc=c5)o)o.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. omaciclovir. this classification denotes an antiviral agent with the molecular formula c10h15n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c9h909gli3, chemically known as 6h-purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-2-(hydroxymethyl)butyl)- (r)-; but generally known as omaciclovir, which bears us nih compound identifier 3047801. the term omaciclovir is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations schedule omaciclovir under hs 29335995 and sitc 51576. as of q4 2014, omaciclovir remains the us fda preferred term for this commodity. omaciclovir bears us nlm identifiers umls id c2983879 and nci concept code c90785. smiles: c1=nc2=c(n1cc(cco)co)nc(=nc2=o)n.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. opaviraline. this classification denotes a reverse transcriptase inhibitor with the molecular formula c14h17fn2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q3a8eu2nmu, chemically known as 1(2h)-quinoxalinecarboxylic acid, 2-ethyl-7-fluoro-3,4-dihydro-3-oxo-, 1-methylethyl ester, (2s)- but generally known as opaviraline, which bears us nih compound identifier 154048. the term opaviraline is an international non-proprietary name. most nations schedule opaviraline under hs 29339990 and sitc 51577. as of q4 2014, opaviraline remains the us fda preferred term for this commodity. opaviraline bears us nlm identifiers umls id c0910816 and nci concept code c90786. smiles: ccc1c(=o)nc2=c(n1c(=o)oc(c)c)c=c(c=c2)f.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. rociclovir. this classification denotes a purine antagonist and antiviral agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6df29u51y7. european medicines agency schedules rociclovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10351mig. rociclovir generally arises in the molecular formula c15h25n5o3. the term rociclovir is an international non-proprietary name or inn. rociclovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rociclovir under hs 29335995 and sitc 51576. as of q4 2014, rociclovir remains the us fda preferred term for this commodity. rociclovir bears us nlm identifiers umls id c0643822 and nci concept code c73204. smiles: o(c(coc(c)c)coc(c)c)cn1c2nc(ncc2nc1)n.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. telinavir. this classification denotes a protease inhibitor with the molecular formula c33h44n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier izf55eh3cg, chemically known as butanediamide, n1-(3-((((1,1-dimethylethyl)amino)carbonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (1s-(1r*,(r*),2s*))- but generally known as telinavir, which bears us nih compound identifier 60874. european medicines agency schedules telinavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10872mig. the term telinavir is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). telinavir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule telinavir under hs 29334910 and sitc 51575. as of q4 2014, telinavir remains the us fda preferred term for this commodity. telinavir bears us nlm identifiers umls id c2699908 and nci concept code c76911. smiles: oc(c(nc(=o)c(nc(=o)c1nc2c(cc1)cccc2)cc(=o)n)cc1ccccc1)cn(cc(c)c)c(=o)nc(c)(c)c.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. viroxime. this classification denotes an antiviral agent with the molecular formula (c17h18n4o3s)2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i5v34wg2be, more generally known as viroxime. european medicines agency schedules viroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00082mig. the term viroxime is an international non-proprietary name or inn. viroxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule viroxime under hs 29350090 and sitc 51580. as of q4 2014, viroxime remains the us fda preferred term for this commodity. smiles: cc(c)s(=o)(=o)n1c2=c(c=cc(=c2)c(=no)c3=cc=cc=c3)n=c1n.. "
"antivirals, synthesized. this classification denotes antivirals composed of multiple constituents, with no dominant constituent.. memotine hydrochloride. this classification denotes an antiviral agent with the molecular formula c17h17no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zp0hnu59mm, chemically known as isoquinoline, 3,4-dihydro-1-(4-methoxyphenoxy)methyl]-, hydrochloride but more generally known as memotine hydrochloride, which bears us nih compound identifier 25350. most nations, for tariff and trade purposes, schedule memotine hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, memotine hydrochloride remains us fdas preferred term for this commodity. memotine hydrochloride bears us nlm identifiers umls id c2981325 and nci concept code c87665. smiles: coc1ccc(cc1)occ2=nccc3c2cccc3.cl.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. . "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. peramivir. this classification denotes an antiviral agent with the molecular formula c15h28n4o4.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qw7y7zr15u, chemically known as cyclopentanecarboxylic acid, 3-((1s)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1s,2s,3r,4r)- but generally known as peramivir, which bears us nih compound identifier 151164. european medicines agency schedules peramivir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32136. most nations schedule peramivir under hs 29252900 and sitc 51482. as of q4 2014, peramivir remains the us fda preferred term for this commodity. peramivir bears us nlm identifiers umls id c1675326 and nci concept code c81611. smiles: oc1c(c(/n=c(/n)n)cc1c(=o)o)c(nc(=o)c)c(cc)cc.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. amdoxovir. this classification denotes a reverse transcriptase inhibitor with the molecular formula c9h12n6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 54i81h0m9c, chemically known as 2,6-diaminopurine dioxolane but generally known as amdoxovir, which bears us nih compound identifier 124088. european medicines agency schedules amdoxovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20547. the term amdoxovir is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). most nations schedule amdoxovir under hs 29349990 and sitc 51579. as of q4 2014, amdoxovir remains the us fda preferred term for this commodity. amdoxovir bears us nlm identifiers umls id c1528970 and nci concept code c76927. smiles: o1c(n2c3nc(nc(n)c3nc2)n)coc1co.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. tilorone. this classification denotes an antiviral agent with the molecular formula c25h34n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o6w7vew6ks, chemically known as 2,7-bis-deae-fluorenone but generally known as tilorone, which bears us nih compound identifier 5475. european medicines agency schedules tilorone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11057mig. the term tilorone is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). tilorone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tilorone under hs 29221980 and sitc 51461. as of q4 2014, tilorone remains the us fda preferred term for this commodity. tilorone bears us nlm identifiers umls id c0040221 and nci concept code c73335. smiles: o(c1cc2c(c3c(c2=o)cc(occn(cc)cc)cc3)cc1)ccn(cc)cc.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. celgosivir. this classification denotes a glucosidase inhibitor and antiviral agent with the molecular formula c12h21no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 895vg117hn, chemically known as mdl 28,574a but generally known as celgosivir, which bears us nih compound identifier 60734. european medicines agency schedules celgosivir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07435mig. the term celgosivir is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). celgosivir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule celgosivir under hs 29339990 and sitc 51577. as of q4 2014, celgosivir remains the us fda preferred term for this commodity. celgosivir bears us nlm identifiers umls id c0287304 and nci concept code c79567. smiles: cccc(=o)o[c@h]1cn2cc[c@@h]([c@@h]2[c@h]([c@@h]1o)o)o.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. celgosivir hydrochloride. this classification denotes an enzyme inhibitor with the molecular formula c12h21no5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70u2nqu0fp, chemically known as castanospermine, 6-o-butyrate hydrochloride but more generally known as celgosivir hydrochloride, which bears us nih compound identifier 3033824. most nations, for tariff and trade purposes, schedule celgosivir hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, celgosivir hydrochloride remains us fdas preferred term for this commodity. celgosivir hydrochloride bears us nlm identifiers umls id c2828312 and nci concept code c87464. smiles: cccc(=o)o[c@h]1cn2cc[c@@h]([c@@h]2[c@h]([c@@h]1o)o)o.cl.. "
"antiviral cyclopentanes and dioxolanes and fluorenes and indolizines. this classification denotes antiviral drugs made from or based in part on cyclopentanes, dioxolanes, fluorenes, or indolizines. tilorone hydrochloride. this classification denotes a cholinergic agonist with the molecular formula c25h34n2o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bj507j4lky, chemically known as 2,7-bis-deae-fluorenone but more generally known as tilorone hydrochloride, which bears us nih compound identifier 5475. most nations, for tariff and trade purposes, schedule tilorone hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, tilorone hydrochloride remains us fdas preferred term for this commodity. tilorone hydrochloride bears us nlm identifiers umls id c0085800 and nci concept code c72868. smiles: ccn(cc)ccoc1ccc-2c(c1)c(=o)c3c2ccc(c3)occn(cc)cc.cl.cl.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. . "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. adefovir. this classification denotes a reverse transcriptase inhibitor with the molecular formula c8h12n5o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6gqp90i798, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)- but generally known as adefovir, which bears us nih compound identifier 60172. adefovir most often comes in dipivoxil and pivoxil forms. european medicines agency schedules adefovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05264mig. the term adefovir is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). adefovir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule adefovir under hs 29335995 and sitc 51576. as of q4 2014, adefovir remains the us fda preferred term for this commodity. adefovir bears us nlm identifiers umls id c0050175 and nci concept code c61526. smiles: c1=nc2=c(c(=n1)n)n=cn2ccocp(=o)(o)o.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. cidofovir. this classification denotes an antiviral agent with the molecular formula c8h14n3o6p.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, jil713q00n chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, dihydrate, (s)- but generally known as cidofovir, which bears us nih compound identifier 60613. european medicines agency schedules cidofovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06257mig. the term cidofovir is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35. ). most nations schedule cidofovir under hs 29335995 and sitc 51576. as of q4 2014, cidofovir remains the us fda preferred term for this commodity. cidofovir bears us nlm identifiers umls id c0286079 and nci concept code c1600. smiles: p(=o)(o)(o)coc(cn1ccc(nc1=o)n)co.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir. this classification denotes a reverse transcriptase inhibitor and purine antagonist with the molecular formula c9h14n5o4p.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99yxe507il, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but generally known as tenofovir, which bears us nih compound identifier 464205. european medicines agency schedules tenofovir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04721mig. most nations schedule tenofovir under hs 29335995 and sitc 51576. as of q4 2014, tenofovir remains the us fda preferred term for this commodity. tenofovir bears us nlm identifiers umls id c0384228 and nci concept code c29490. smiles: p(=o)(o)(o)coc(cn1c2ncnc(n)c2nc1)c.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. adefovir dipivoxil. this classification denotes an acyclic nucleotide adenine antiviral with the molecular formula c20h32n5o8p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6q8z01514, chemically known as propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester but more generally known as adefovir dipivoxil, which bears us nih compound identifier 60871. european medicines agency schedules adefovir dipivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12454mig. world health organization schedules adefovir dipivoxil in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule adefovir dipivoxil under hs 29335995 and sitc 51576. as of q4 2014, adefovir dipivoxil remains us fdas preferred term for this commodity. adefovir dipivoxil bears us nlm identifiers umls id c0540694 and nci concept code c28811. smiles: cc(c)(c)c(=o)ocop(=o)(coccn1cnc2c1ncnc2n)ococ(=o)c(c)(c)c.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. adefovir pivoxil. this classification denotes a reverse transcriptase inhibitor with the molecular formula c20h32n5o8p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6q8z01514, chemically known as adefovir di(pivaloyloxymethyl) ester [mi], but more generally known as adefovir pivoxil, which bears us nih compound identifier 60871. european medicines agency schedules adefovir pivoxil or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05264mig. most nations, for tariff purposes, schedule adefovir pivoxil under hs 29335995. smiles: cc(c)(c)c(=o)ocop(=o)(coccn1cnc2c1ncnc2n)ococ(=o)c(c)(c)c.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. cidofovir anhydrous. this classification denotes an antiviral agent with the molecular formula c8h14n3o6p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 768m1v522c, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (s)-, but more generally known as cidofovir anhydrous, which bears us nih compound identifier 60613. european medicines agency schedules cidofovir anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06257mig. most nations, for tariff purposes, schedule cidofovir anhydrous under hs 29335995. cidofovir anhydrous bears us nlm identifiers umls id c2699210 and nci concept code c77925. smiles: c1cn(c(=o)nc1n)c[c@@h](co)ocp(=o)(o)o.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. cidofovir sodium. this classification denotes an antiviral agent with the molecular formula c8h12n3o6p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m83jb37u61, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, disodium salt, (s)-, but more generally known as cidofovir sodium, which bears us nih compound identifier 135406. european medicines agency schedules cidofovir sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06257mig. most nations, for tariff purposes, schedule cidofovir sodium under hs 29335995. smiles: c1cn(c(=o)nc1n)c[c@@h](co)ocp(=o)([o-])[o-].[na+].[na+].. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir alafenamide. this classification denotes a reverse transcriptase inhibitor and purine antagonist c21h29n6o5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier el9943ag5j, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, but more generally known as tenofovir alafenamide, which bears us nih compound identifier 9574768. most nations, for tariff and trade purposes, schedule tenofovir alafenamide under hs 29335995 and sitc 51576. as of q4 2014, tenofovir alafenamide remains us fdas preferred term for this commodity. smiles: c[c@h](cn1cnc2c1ncnc2n)oc[p@@](=o)(n[c@@h](c)c(=o)oc(c)c)oc3ccccc3.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir alafenamide fumarate. this classification denotes a reverse transcriptase inhibitor and purine antagonist 2c21h29n6o5p.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fwf6q91tzo, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, (2e)-2-butenedioate (2:1), but more generally known as tenofovir alafenamide fumarate, which bears us nih compound identifier 71301443. most nations, for tariff and trade purposes, schedule tenofovir alafenamide fumarate under hs 29335995 and sitc 51576. as of q4 2014, tenofovir alafenamide fumarate remains us fdas preferred term for this commodity. smiles: c[c@h](cn1cnc2c1ncnc2n)oc[p@@](=o)(n[c@@h](c)c(=o)oc(c)c)oc3ccccc3.c[c@h](cn1cnc2c1ncnc2n)oc[p@@](=o)(n[c@@h](c)c(=o)oc(c)c)oc3ccccc3.c(=c/c(=o)o)\\c(=o)o.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir df. this classification denotes a reverse transcriptase inhibitor and purine antagonist with the molecular formula c19h30n5o10p.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ott9j7900i, chemically known as bis(hydroxymethyl) (((r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phosphonate, bis(isopropyl carbonate) (ester), fumarate (1:1), but more generally known as tenofovir df, which bears us nih compound identifier 6398764. european medicines agency schedules tenofovir df or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04721mig. most nations, for tariff purposes, schedule tenofovir df under hs 29335995. smiles: c[c@h](cn1cnc2c1ncnc2n)ocp(=o)(ococ(=o)oc(c)c)ococ(=o)oc(c)c.c(=c/c(=o)o)\\c(=o)o.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir disoproxil. this classification denotes a reverse transcriptase inhibitor and purine antagonist c19h30n5o10p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f4yu4lon7i, chemically known as 2,4,6,8-tetraoxa-5-phosphanonanedioic acid, 5-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, 1,9-bis(1-methylethyl) ester, 5-oxide, but more generally known as tenofovir disoproxil, which bears us nih compound identifier 5481350. european medicines agency schedules tenofovir disoproxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20643. most nations, for tariff and trade purposes, schedule tenofovir disoproxil under hs 29335995 and sitc 51576. world health organization schedules tenofovir disoproxil in its anatomical therapeutic chemical (atc) classification. as of q4 2014, tenofovir disoproxil remains us fdas preferred term for this commodity. smiles: c[c@h](cn1cnc2c1ncnc2n)ocp(=o)(ococ(=o)oc(c)c)ococ(=o)oc(c)c.. "
"antiviral organophosphorus compounds. antiviral drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. tenofovir disoproxil fumarate. this classification denotes a reverse transcriptase inhibitor with the molecular formula c19h30n5o10p.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ott9j7900i, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but more generally known as tenofovir disoproxil fumarate, which bears us nih compound identifier 464205. european medicines agency schedules tenofovir disoproxil fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12607mig. most nations, for tariff and trade purposes, schedule tenofovir disoproxil fumarate under hs 29335995 and sitc 51576. as of q4 2014, tenofovir disoproxil fumarate remains us fdas preferred term for this commodity. tenofovir disoproxil fumarate bears us nlm identifiers umls id c1099776 and nci concept code c47747. smiles: c[c@h](cn1cnc2c1ncnc2n)ocp(=o)(ococ(=o)oc(c)c)ococ(=o)oc(c)c.c(=c/c(=o)o)\\c(=o)o.. "
"antiviral thiosemicarbazones. antiviral drugs made from imines derivatives.. . "
"antiviral thiosemicarbazones. antiviral drugs made from imines derivatives.. citenazone. this classification denotes an antiviral agent with the molecular formula c7h6n4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 34ru0n173q, chemically known as 2-thiophenecarbonitrile, 5-formyl-, thiosemicarbazone but generally known as citenazone, which bears us nih compound identifier 3033956. european medicines agency schedules citenazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07488mig. the term citenazone is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). citenazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule citenazone under hs 29349990 and sitc 51579. as of q4 2014, citenazone remains the us fda preferred term for this commodity. citenazone bears us nlm identifiers umls id c0602975 and nci concept code c87472. smiles: s1c(ccc1c#n)/c=n/nc(=s)n.. "
"antiviral thiosemicarbazones. antiviral drugs made from imines derivatives.. methisazone or metisazone. this classification denotes an antiviral agent with the molecular formula c10h10n4os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k3qml4j07e, chemically known as 1-methylindole-2,3-dione 3-(thiosemicarbazone) but generally known as methisazone, which bears us nih compound identifier 6861563. european medicines agency schedules metisazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08895mig. the term methisazone is an international non-proprietary name. world health organization schedules methisazone in its anatomical therapeutic chemical (atc) classification. methisazone or metisazone bears us nlm identifiers umls id c0025656 and nci concept code c77928. smiles: cn1c2=cc=cc=c2c(=nnc(=s)n)c1=o.. "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. . "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. tanomastat. this classification denotes a matrix metalloproteinase inhibitor with the molecular formula c23h19clo3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier am1zx94exh, chemically known as (s)-4-chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1-biphenyl)-4-butanoic acid but generally known as tanomastat, which bears us nih compound identifier 177347. the term tanomastat is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule tanomastat under hs 29309085 and sitc 51549. as of q4 2014, tanomastat remains the us fda preferred term for this commodity. tanomastat bears us nlm identifiers umls id c0393069 and nci concept code c1705. smiles: c1ccc(cc1)sc[c@@h](cc(=o)c2ccc(cc2)c3ccc(cc3)cl)c(=o)o.. "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. moroxydine. this classification denotes an anti-infective agent with the molecular formula c6h13n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o611591wah, chemically known as 4-morpholinecarboximidamide, n- (aminoiminomethyl)-, monohydrochloride but generally known as moroxydine, which bears us nih compound identifier 71655. european medicines agency schedules moroxydine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09070mig. the term moroxydine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules moroxydine in its anatomical therapeutic chemical (atc) classification. moroxydine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moroxydine under hs 29349990 and sitc 51579. as of q4 2014, moroxydine remains the us fda preferred term for this commodity. moroxydine bears us nlm identifiers umls id c0066805 and nci concept code c66200. smiles: o1ccn(cc1)c(=n)/n=c(/n)n.. "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. rilpivirine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c22h18n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fi96a8x663, chemically known as 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile but generally known as rilpivirine, which bears us nih compound identifier 6451164. european medicines agency schedules rilpivirine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31456. the term rilpivirine is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53). most nations schedule rilpivirine under hs 29335995 and sitc 51576. as of q4 2014, rilpivirine remains the us fda preferred term for this commodity. rilpivirine bears us nlm identifiers umls id c1566826 and nci concept code c76929. smiles: n(c1c(cc(cc1c)/c=c/c#n)c)c1nc(nc2ccc(cc2)c#n)ncc1.. "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. etravirine. this classification denotes a reverse transcriptase inhibitor with the molecular formula c20h15brn6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0c50hw4fo1, chemically known as benzonitrile, 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl- but generally known as etravirine, which bears us nih compound identifier 193962. european medicines agency schedules etravirine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25650. the term etravirine is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules etravirine in its anatomical therapeutic chemical (atc) classification. most nations schedule etravirine under hs 29335995 and sitc 51576. as of q4 2014, etravirine remains the us fda preferred term for this commodity. etravirine bears us nlm identifiers umls id c1456409 and nci concept code c73195. smiles: brc1c(oc2c(cc(cc2c)c#n)c)nc(nc2ccc(cc2)c#n)nc1n.. "
"antiviral ketones and morpholines and nitriles and pyridazines. this classification denotes antiviral drugs made from or based in part on ketones, morpholines, nitriles, or pyridazines. rilpivirine hydrochloride. this classification denotes a reverse transcriptase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 212wax8kdd. european medicines agency schedules rilpivirine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31460. rilpivirine hydrochloride generally arises in the molecular formula c22h18n6.clh. the term rilpivirine hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule rilpivirine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, rilpivirine hydrochloride remains us fdas preferred term for this commodity. smiles: cc1cc(cc(c1nc2ccnc(n2)nc3ccc(cc3)c#n)c)/c=c/c#n.cl.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. . "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. abacavir/lamivudine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals. the first component of this combination drug is a reverse transcriptase inhibitor with the molecular formula c14h18n6o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier wr2tip26vs, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, (1s-cis)- but more generally known as abacavir, which bears u.s. national institutes of health compound identifier 65140. abacavir most often appears in forms succinate and sulfate, and is sometimes combined with lamivudine and zidovudine. the european medicines agency schedules abacavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07356mig. the term abacavir is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38). the world health organization schedules abacavir in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a reverse transcriptase inhibitor with the molecular formula c8h11n3o3s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 2t8q726o95, chemically known as 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone but more generally known as lamivudine, which bears u.s. national institutes of health compound identifier 60825. the european medicines agency schedules lamivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08392mig. the term lamivudine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). the world health organization schedules lamivudine in its anatomical therapeutic chemical (atc) classification.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. abacavir/lamivudine/zidovudine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals. the first component of this combination drug is a reverse transcriptase inhibitor with the molecular formula c14h18n6o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier wr2tip26vs, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, (1s-cis)- but more generally known as abacavir, which bears u.s. national institutes of health compound identifier 65140. abacavir most often appears in forms succinate and sulfate, and is sometimes combined with lamivudine and zidovudine. the european medicines agency schedules abacavir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07356mig. the term abacavir is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38). the world health organization schedules abacavir in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a reverse transcriptase inhibitor with the molecular formula c8h11n3o3s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 2t8q726o95, chemically known as 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone but more generally known as lamivudine, which bears u.s. national institutes of health compound identifier 60825. the european medicines agency schedules lamivudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08392mig. the term lamivudine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). the world health organization schedules lamivudine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a reverse transcriptase inhibitor, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 4b9xt59t7s. the european medicines agency schedules zidovudine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00153mig. zidovudine generally arises in the molecular formula c10h13n5o4. the term zidovudine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27.). "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. efavirenz/emtricitabine/tenofovir. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. emtricitabine/tenofovir. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. interferon alfa-2b/ribavirin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. lamivudine/zidovudine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. peginterferon/ribavirin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am800. this va drug class (am800) classifies this compound as belonging to the group antivirals.. "
"combination antivirals. this classification denotes combination drugs used in the prophylaxis or therapy of viral diseases (or diseases that viruses cause), which operate by preventing viral replication by inhibiting viral dna polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. typical combination antiviral constituents are abacavir, efavirenz, emtricitabine, interferon alfa-2b, lamivudine, lopinavir, and peginterferon.. elvitegravir/cobicistat/emtricitabine/tenofovir. a multi-drug combination indicated as a complete regimen for the treatment of hiv-1.. "
